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CHAPTER I 
 
INTRODUCTION 
 
Introduction to pre-mRNA splicing 
All organisms have genomes that are transcribed by polymerases. In eukaryotes, 
the resulting pre-messenger RNA (pre-mRNA) may contain intervening sequences 
(introns) that must be removed so that the remaining sequences (exons) can be joined 
together and form the mature mRNA. The process of intron removal and exon ligation is 
termed pre-mRNA splicing. Splicing is a highly regulated step in gene expression, 
extensively coupled to preceding and following steps in the mRNA’s maturation 
(reviewed in Montes, Becerra et al. 2012 and Pawlicki and Steitz 2010). When we 
consider a single intron surrounded by two exons (exon 1 and exon 2), the splicing 
chemistry depends on three sequence features within the intron: the 5’ splice site (SS), 
the branch point, and the 3’ SS. In the first reaction step, the 2’ hydroxyl of the branch 
point adenosine attacks the 5’ SS phosphate, releasing the sequence 5’ of the intron (exon 
1), and forming a lariat intermediate. In the second step, the 3’ hydroxyl of exon 1 attacks 
the phosphate at the 3’ SS, joining exon 1 with the sequence downstream of the intron, 
termed exon 2. The ligated exons are included in the mRNA to be translated by the 
ribosome, while the intron, in lariat form, is discarded. 
Because splicing alters the mRNA sequence, fidelity of this process is of great 
importance to proper gene expression. In an average human gene, a sequence of 28,000 
nucleotides contains nine relatively short exons (120 nucleotides each) alternatively 
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interspersed with eight introns of between 100 and 100,000 nucleotides each (Lander, 
Linton et al. 2001). The choice of splice sites can be changed by mutation of a single 
nucleotide, and many genetic diseases are caused by such single nucleotide changes 
(reviewed in Singh and Cooper 2012). Transcripts in higher eukaryotes often undergo 
differential patterns of splicing depending on cell type, stage of development, and other 
signals, a process termed alternative splicing (Pan, Shai et al. 2008, Wang, Sandberg et al. 
2008). In this process, the normal, or constitutive, pattern of intron/exon boundaries is 
modified in some fashion, leading to such transcript changes as exon exclusion, exon 
length modifications, and intron inclusion (Maniatis and Tasic 2002). Alternative splicing 
thus functions to increase the number of potential proteins that can be coded by a single 
gene.  
 
Spliceosome machinery 
The regulation of splice site choice and facilitation of splicing chemistry are 
performed by a ubiquitous eukaryotic machine termed the spliceosome. Our current 
knowledge of splicing factors and their interactions within the spliceosome comes from 
many decades of research. The first genetic means of defining splicing factors was a 
screen in 1967 by L. Hartwell, who isolated Saccharomyces cerevisiae temperature 
sensitive (ts) mutants with RNA synthesis defects (Hartwell 1967). M. Rosbash and 
colleagues later demonstrated that some of Hartwell’s RNA synthesis mutants had 
defects in splicing (reviewed in Ruby and Abelson 1991), and termed the 
complementation groups PRP (precursor RNA processing). Using in vitro splicing assays, 
developed in the 1980s (Cheng, Newman et al. 1990 and references therein), groups 
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confirmed many PRP factors have direct involvement in the splicing reaction. As 
additional splicing factors continued to be discovered genetically using S. cerevisiae, 
screens for splicing mutants in the fission yeast Schizosaccharomyces pombe led to the 
definition of PRP groups in that organism (Potashkin, Li et al. 1989, Urushiyama, Tani et 
al. 1996). Early biochemical work using HeLa cells led to the hypothesis that structural 
RNA molecules termed small nuclear RNAs (snRNAs) were required for splicing (Yang, 
Lerner et al. 1981). These uridine-rich snRNAs include U1, U2, U4, U5, and U6. The 
same types of experiments were used to isolate each snRNA and its associating protein 
components, together termed the small nuclear ribonucleoproteins (snRNPs) (for example, 
Lerner and Steitz 1979, Bringmann, Appel et al. 1984, Bach, Winkelmann et al. 1989, 
Behrens, Tyc et al. 1993). The U1, U2, U4, and U5 snRNA are packaged with a common 
set of stabilizing proteins, termed the Sm ring, while the U6 snRNA is stabilized by a 
similar structure, termed the Lsm ring. The snRNA, Sm or Lsm ring, and other proteins 
specific to each snRNA together organize into a snRNP.  
HeLa cell in vitro splicing assays revealed that each snRNP is only required for a 
portion of the splicing reaction (Bindereif and Green 1987). The in vitro splicing assays 
from both budding yeast and HeLa cells led to a model of spliceosome assembly and 
catalysis defined by ordered binding and dissociation of snRNPs.  In this model, 
spliceosome assembly begins with the recognition of the 5’ SS, branch point, and 
polypyrimidine tract downstream of the branch point by the U1 snRNP, the SF1 protein, 
and the U2 auxilary factor (U2AF), respectively. Afterwards, in an ATP-dependent step, 
the U2 snRNA basepairs with the branch point, forming Complex A (Figure 1-1). The 
subsequent engagement of the U5.U4/U6 tri-snRNP at Complex B triggers the unwinding 
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FIGURE 1-1
Schematic model of a single round of pre-mRNA splicing
U1, U2, U4, U5, and U6 represent snRNPs. NTC stands for the Prp nineteen complex.
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of the U4/U6 snRNA duplex that is then replaced with the U2/U6 snRNA duplex. 
Furthermore the U1 snRNA base pairing at the 5’ splice site is disrupted and exchanged 
for base pairing between the 5’ splice site and the U6 snRNA. The subsequent release of 
the U1 and U4 snRNPs marks the transition from the inactive to active spliceosome, 
termed Complex B’. The activated Complex B’ catalyzes the first transesterification 
reaction, and Complex C catalyzes the second transesterification reaction. The post-
catalytic complex then releases the mRNA and disassembles. 
In addition to the snRNP specific components, the spliceosome contains hundreds 
of additional proteins that associate with the complex at different points in the reaction. 
While many of these pre-mRNA splicing factors join and leave the spliceosome singly, 
there is one group of proteins that appears to join as a complex, termed the NTC for its 
founding member (Prp nineteen complex) (Tarn, Hsu et al. 1994, Tsai, Chow et al. 1999, 
Agafonov, Deckert et al. 2011). The NTC binds following Complex B formation and is 
required for spliceosome activation (Chan, Kao et al. 2003, Makarova, Makarov et al. 
2004). The advent of mass spectrometry for identification of proteins in purifications was 
used with in vitro spliceosomes stalled at various stages of assembly to determine the full 
complement of proteins present at each stage and revealed that the protein composition of 
the spliceosome changes dramatically during a splice cycle (Hartmuth, Urlaub et al. 2002, 
Jurica, Licklider et al. 2002, Makarov, Makarova et al. 2002, Makarova, Makarov et al. 
2004, Deckert, Hartmuth et al. 2006, Behzadnia, Golas et al. 2007, Bessonov, Anokhina 
et al. 2008, Fabrizio, Dannenberg et al. 2009). Particularly exciting was the application of 
a novel semiquantiative proteomic analysis method to show that many spliceosome 
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proteins associate sub-stoichiometrically (Agafonov, Deckert et al. 2011), indicating that 
such proteins are not required to splice every substrate. 
The composition of the active site and the identity of the molecules that 
accomplish actual catalysis at Complexes B’ and C are still unclear. RNPs, which 
catalyze many cellular reactions besides splicing, can contain an RNA and/or protein-rich 
active site. In true ribozymes, the RNA catalyzes the reaction, and RNP proteins play 
supporting roles, while protein-catalyzed RNPs use only proteins for catalysis. Genetic 
and biochemical analyses have clearly demonstrated that both proteins and snRNAs are 
required for the splicing reaction in the context of the spliceosome; however, the 
spliceosome’s status as a ribozyme is unclear. Our current understanding of RNA/RNA 
pairing in the active site is illustrated in Figure 1-2. The U2 and U6 snRNAs are 
extensively base-paired to each other, and each strand contacts the substrate – U2 
contacts the branch point and U6 contacts the 5’ SS. The U5 snRNA is also present and is 
thought to align the two exons for second step catalysis (Sontheimer and Steitz 1993). In 
vitro, a system containing only portions of U6, U2, and the pre-mRNA was able to 
catalyze a reaction similar to the first step of splicing (Valadkhan and Manley 2001). 
There are a handful of proteins present near the active site, including U5 snRNP proteins 
Prp8, Brr2, and Snu114. Regarding proteins that may catalyze splicing, Prp8, a 
component of the U5 snRNP, can be crosslinked to the 5’ SS, branch point, and 3’ SS 
prior to catalysis (reviewed in Grainger and Beggs 2005). A recent crystal structure of a 
large portion of Prp8 revealed that it forms a cavity large enough to contain the self-
splicing RNA structures of a group II intron, which undergoes the same two-step 
chemistry as spliceosome-processed pre-mRNA (Galej, Oubridge et al. 2013). High-
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FIGURE 1-2
Model of two-dimensional RNA/RNA interactions in the active site
The sequences of S. pombe U2, U5, and U6 are shown. U5 loop 1 is shown contacting the
pre-mRNA exons, while the U2 and U6 sequences, extensively base-paired, contact the
branch point and 5’ splice site, respectively. Nucleic acids in blue are known to be involved 
in the active site.
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resolution structural data of the active site would be required, however, to fully visualize 
the proteins, RNA, or both that participate in catalysis. 
 
Structural characterization of splicing complexes 
Structural characterization on the spliceosome has lagged behind genetic and 
biochemical analyses due to certain peculiarities of the complex. Superficially, the 
spliceosome appears to be similar in complexity to another large RNP, the ribosome, 
which has been successfully structurally modeled through both electron microscopy (EM) 
and x-ray crystallography (Taylor, Nilsson et al. 2007, Ben-Shem, Jenner et al. 2010). 
However, the mechanisms of function are quite different between the two complexes. 
Once the ribosome is in elongation mode, it has pre-formed active sites that can function 
outside of the context of the entire complex, while the spliceosome and its active sites 
form de novo on the substrate for each round of splicing. The compositional 
heterogeneity of the spliceosome at each splicing intermediate and the sub-stoichiometric 
association of many spliceosome proteins are additional challenges unique to the 
spliceosome. Interactions observed in, for example, the pre-engagement U5 snRNP are 
unlikely to be entirely preserved in the catalytically active spliceosome due to the many 
actions of enzymes during spliceosome assembly (see section Facilitation of Spliceosome 
Dynamics below). Many spliceosome proteins are predicted to be unstructured out of the 
context of their binding partners (Korneta, Magnus et al. 2012, Coelho Ribeiro, Espinosa 
et al. 2013), which makes characterization of these smaller units by crystallization 
difficult. Finally, spliceosomes are large complexes with dozens of unique proteins, 
making reconstitution from purified individual components prohibitive. 
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Current structural data on the spliceosome has been extensively reviewed 
elsewhere (Zhang, Li et al. 2013) and is composed mostly of high-resolution 
crystallography and NMR structures of the domains of individual pre-RNA splicing 
factors and of low-resolution single-particle EM structures of entire splicing complexes. 
Some of the most informative high-resolution data so far include two crystal structures of 
the human U1 snRNP at 5.5 Å (Pomeranz Krummel, Oubridge et al. 2009) and 4.4 Å 
(Weber, Trowitzsch et al. 2010) resolution. These structures are complex, including the 
snRNA, the entire Sm ring, and the three U1-specific proteins. These studies enhanced 
our understanding of the Sm ring/snRNA interaction and revealed U1-70K’s capacity to 
link the snRNA with another U1 specific protein through discrete domains. Additionally, 
a model of the U4 snRNP core at 3.6 Å resolution showed direct one-to-one interactions 
between the seven nucleotides of the U4 snRNA “Sm site heptad” and the seven Sm 
proteins taking place in the central canal of the Sm ring (Leung, Nagai et al. 2011). 
Regarding spliceosome proteins, several domains of U5-snRNP protein Prp8 have 
been crystallized (Pena, Liu et al. 2007, Zhang, Shen et al. 2007, Pena, Rozov et al. 2008, 
Ritchie, Schellenberg et al. 2008, Yang, Zhang et al. 2008). The largest structure, with 
~1000 residues of Prp8 in complex with assembly factor Aar2 at 1.9 Å, revealed the 
presence of Prp8 domains similar to bacterial and fungal Group II intron-encoded 
proteins (IEPs) (Galej, Oubridge et al. 2013). Because the splicing reaction is similar to a 
Group II intron self-splicing event, and because the IEPs act upon the Group II intron 
following splicing, the structural model revealed a remarkable adaptation of these ancient 
proteins for use in the spliceosome catalytic core. A protein domain successfully 
crystallized and analyzed by NMR is the RNA-recognition motif (RRM), present in 
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multiple spliceosomal proteins (reviewed in Zhang, Li et al. 2013), and able to bind either 
canonically to RNA or, by adaptations, to other proteins. And finally, multiple RNA 
helicases, which drive conformational changes and proofread within the spliceosome, 
have been crystallized, including Prp43 (He, Andersen et al. 2010, Walbott, Mouffok et 
al. 2010), which has high sequence similarity to other spliceosomal helicases including 
Prp2, Prp16, and Prp22. Also, a large portion of Brr2, the only helicase that is an integral 
member of a snRNP (U5), was crystallized at 2.7 Å (Santos, Jovin et al. 2012). Brr2 is a 
250-kDa protein that contains two tandem helicase cassettes, and the structure revealed 
the interaction of the catalytically active N-terminal cassette with the C-terminal cassette, 
which cannot hydrolyze ATP but contacts binding partners and regulates N-terminal 
cassette activity. 
Because of the challenges of crystallizing large complexes, EM has been the 
preferred method to interrogate the structural organization of entire spliceosomes. 
However, the low-resolution structures obtained thus far have been useful mainly in 
defining the general shapes of the complexes. Currently there are three-dimensional 
structures for the yeast U5.U4/U6 tri-snRNP (Hacker, Sander et al. 2008), yeast U6 
snRNP (Karaduman, Dube et al. 2008), the human U5.U4/U6 tri-snRNP (21 Å 
resolution), and its components, U5 snRNP (26-32 Å resolution) and U4/U6 snRNPs (40 
Å resolution) (Sander, Golas et al. 2006). The two tri-snRNP papers, with included 
labeling studies, satisfyingly demonstrated the organization of the tri-snRNP, with U5-
snRNP proteins Prp8 and Snu114 present in the main body, and the U4/U6 di-snRNP and 
Brr2 forming two projections both upwards from the main body. Concerning spliceosome 
intermediates, there are 3D structural models of human complex A at 40-50 Å resolution 
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(Behzadnia, Golas et al. 2007), human BΔU1 at 40 Å resolution (Boehringer, Makarov et 
al. 2004), human C at 20-29 Å resolution (Golas, Sander et al. 2010), and a much smaller 
human C structure at 30 Å resolution (Jurica, Sousa et al. 2004). Disparities between the 
two C complex structures have not been fully explained; however, the fixation protocol 
used to prepare spliceosomes in (Golas, Sander et al. 2010) appears to account for at least 
some of the differences (Ilagan, Chalkley et al. 2013). Figure 1-3 shows the splicing 
intermediate structures, as well as the human tri-snRNP structure (Sander, Golas et al. 
2006) at proper scale relative to each other. These structures highlight the huge 
conformational and size changes the spliceosome undergoes throughout a single splicing 
cycle. An additional cryo-EM structure of an endogenous S. pombe spliceosome at 29 Å 
resolution (Ohi, Ren et al. 2007) is strikingly similar in size and shape to the smaller 
human C complex (Jurica, Sousa et al. 2004), suggesting high conservation of overall 
spliceosome structure from fission yeast to humans. 
In addition to the challenges to structural determination outlined at the beginning 
of this section, single-particle EM analysis of spliceosomes requires overcoming 
additional spliceosome-specific issues, including conformational heterogeneity and lack 
of symmetry. One goal of our lab, and others, is to improve the sample quality of 
spliceosomes through genetic and biochemical manipulation as well as purification 
strategies. Improved samples, along with the continual advances in analysis software and 
processing power, promise to expand the information EM can reveal about splicing 
complexes. 
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FIGURE 1-3
Comparison of current 3D EM structures of human spliceosome intermediates
The spliceosome stage and major components are listed below each structure. 1) Behzadnia,
et al., 2007,  2) Sander, et al., 2006,  3) Boehringer, et al., 2004,  4) Golas, et al., 2010,  5) 
Jurica, et al., 2004. Scale bar (between structures 1 and 2) indicates 100 Å. 
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Facilitation of spliceosome dynamics 
Because of the massive conformational and compositional changes that happen 
between intermediates in the splicing cycle, we would like to know how these changes 
are facilitated. The list of spliceosome-associated proteins contains a number of 
candidates with enzymatic activity, including evolutionarily conserved DEAD-box 
(DExD/H) ATPase helicases, a ubiquitin ligase, kinases, phosphatases, and a GTPase 
(Staley and Guthrie 1998, Will and Lührmann 2011, van der Feltz, Anthony et al. 2012). 
The GTPase, Snu114/Cwf10, will be discussed at length in a following section. The eight 
spliceosome-associated helicases are the best-studied transition-related enzymes, and 
they function at discrete stages of spliceosome assembly, activation, and disassembly 
(Staley and Guthrie 1998). Helicases generally act by either binding dsRNA and 
unwinding the strands locally, or by translocating along a single RNA strand until a 
duplex is encountered and displaced (Jankowsky, Gross et al. 2000, Yang, Del Campo et 
al. 2007). DExD/H box helicases can also disrupt protein/RNA interactions (Jankowsky, 
Gross et al. 2001). Thus, it is proposed that the spliceosome helicases unwind RNA 
duplexes or displace RNA-bound proteins while translocating along the RNA. 
Spliceosome helicases also function at splicing fidelity checkpoints by delaying splicing 
progression of sub-optimal substrates such that a discard pathway is used (Koodathingal, 
Novak et al. 2010, Mayas, Maita et al. 2010). While helicase function is absolutely 
required for some spliceosome transitions in vitro, many of the helicase targets are 
unknown (Cordin, Hahn et al. 2012). 
The spliceosome contains at least one known ubiquitin ligase, Prp19, which 
ubiquitylates the U4 snRNP protein Prp3, increasing its affinity for U5 protein Prp8 and 
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encouraging assembly of the U5.U4/U6 tri-snRNP (Song, Werner et al. 2010). 
Deubiquitylation of Prp3 during spliceosome activation is presumed to encourage 
ejection of U4 and tri-snRNP-specific proteins from the spliceosome during activation. A 
separate set of experiments demonstrated similar roles for ubiquitylation in tri-snRNP 
integrity and spliceosome activation, although the targets were not identified (Bellare, 
Small et al. 2008).  
Kinases and phosphatases are also required for spliceosome transitions, although 
it is likely that some of these events are not conserved in budding yeast, which lacks a 
gene encoding the spliceosome-specific kinase Prp4. Kinase activity by human Prp4, 
however, is required for Complex B formation (Schneider, Hsiao et al. 2010). 
Furthermore, Prp28 phosphorylation by SRPK2 likely plays a role in Complex B 
formation (Mathew, Hartmuth et al. 2008). Phosphatases PP1 and PP2A are required for 
the first-to-second step catalytic transition in human splicing (Shi, Reddy et al. 2006). 
These results, and the increasing number of phosphorylated human splicing factors being 
reported (Agafonov, Deckert et al. 2011), suggest phosphorylation may be a master 
regulator of spliceosome function.  
 
Functions and components of the U5 snRNP 
The U5 snRNP is a substrate and/or driver in many of the splice cycle transitions, 
mostly due to the U5-specific proteins. Before engaging the spliceosome, the U5 snRNP 
incorporates in to the U5.U4/U6 tri-snRNP. Following splice site selection in Complex A, 
the tri-snRNP joins the spliceosome in Complex B. The U5 snRNP here undergoes major 
changes, as some U5-specific proteins are ejected from the spliceosome, the NTC joins, 
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and the mature active site, likely in the vicinity of U5 snRNP protein Prp8, is formed 
(Galej, Oubridge et al. 2013, Schellenberg, Wu et al. 2013). The U5 snRNP core and at 
least proteins Prp8, Brr2, Snu114, and U5-40 remain with the spliceosome through both 
steps of catalysis and mRNA release (Fabrizio, Dannenberg et al. 2009, Agafonov, 
Deckert et al. 2011, Fourmann, Schmitzova et al. 2013). The U5 snRNA, specifically 
loop 1 (L1), is required for tethering of the two exons prior to their ligation in catalytic 
step two (O'Keefe and Newman 1998). Another element of the U5 snRNA, internal loop 
1 (IL1), acts as an assembly platform for U5 snRNP proteins Brr2, Prp8, and Snu114 
(Nancollis, Ruckshanthi et al. 2013). In addition to potentially housing the active site, 
Prp8 can be mutated to affect both steps of catalysis, and the protein physically contacts 
the 5’ and 3’ splice sites, the intron’s branch point sequence, and the U5 and U6 snRNAs 
(Dix, Russell et al. 1998, Grainger and Beggs 2005, Turner, Norman et al. 2006). Brr2, 
an RNA helicase, is required for spliceosome remodeling events, specifically the 
disruption of U4/U6 interactions (Maeder, Kutach et al. 2009) and the release of U6 from 
U2 in spliceosome disassembly (Small, Leggett et al. 2006). Snu114 contains a GTPase 
domain and, in vitro, is required for Brr2 function, modulating Brr2’s ATPase activity 
(Small, Leggett et al. 2006, Maeder, Kutach et al. 2009). These three proteins, Prp8, Brr2, 
and Snu114, interact amongst each other both physically and genetically (Brenner and 
Guthrie 2005, Boon, Norman et al. 2006, Liu, Rauhut et al. 2006, Zhang, Xu et al. 2009, 
Mozaffari-Jovin, Wandersleben et al. 2013), suggesting that these proteins coordinate to 
control certain spliceosome transitions. 
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Structure and function of the spliceosomal GTPase 
The GTPase Snu114 appears to be a ribosomal protein re-engineered for use in 
the spliceosome. S. cerevisiae Snu114 shares 27% sequence identity with S. cerevisiae 
Eft1/EF2, a ribosomal translocase (Fabrizio, Laggerbauer et al. 1997). EF2 functions in 
eukaryotic translation similarly to its better-studied bacterial homolog, EF-G. During the 
elongation phase of translation, EF-G favors tRNA translocation by driving a 
conformational change in the ribosome (reviewed in Rodnina and Wintermeyer 2011), 
and GTP hydrolysis is required for optimal translocation efficiency (Rodnina, 
Savelsbergh et al. 1997). While EF2/EF-G’s interactions and binding partners within the 
ribosome are known, and include both RNAs and other proteins (Spahn, Gomez-Lorenzo 
et al. 2004, Taylor, Nilsson et al. 2007, Sengupta, Nilsson et al. 2008), the exact sequence 
of events – how GTP hydrolysis leads to the ribosome’s conformational changes – is 
unknown. Inter-domain movement, however, appears to be important, as crosslinking of 
domains I and V inactivates the protein’s translocation function (Peske, Matassova et al. 
2000), and it is known that GTP hydrolysis causes movement of domain IV relative to 
domains I and II (Stark, Rodnina et al. 2000, Jørgensen, Ortiz et al. 2003). 
We made use of crystal structures of EF2 (Jørgensen, Ortiz et al. 2003) to model 
Snu114’s homolog in Schizosaccharomyces pombe, Cwf10 (Figure 1-4A). The domain 
map of Cwf10 (Figure 1-4B) is colored to match the 3D representation in Figure 1-4A. In 
addition to the EF2-like portion, Cwf10/Snu114 contains an N-terminal extension (NTE) 
that is not present in EF2. The NTE has approximately 120 amino acids and, at least 
based on primary sequence, is not homologous to any known domain or motif. 
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FIGURE 1-4
A
B
Structural model of spliceosomal GTPase Cwf10
A) Cwf10 three-dimensional model, as threaded on to the determined structure of EF2 (PDB 
1N0V). B) Linear representation of the domains of Cwf10, as defined by homology to EF2. 
Domains are colored as in A. The 120 amino acid N-terminal extension (NTE) is not conserved 
in EF2 and is not modeled.
90°
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What can our knowledge of EF2/EF-G predict about Snu114’s mechanisms? 
Snu114 likely retains the capacity to bind both proteins and RNA. Indeed Snu114 is able 
to crosslink to the pre-mRNA polypyrimidine tract (Chiara, Palandjian et al. 1997) and 
U5 snRNA IL1 (Dix, Russell et al. 1998). The GTPase activity of Snu114 is predicted to 
be required for optimal function; however, evidence suggests that nucleotide binding 
status, but not hydrolysis, is important for Snu114’s role in U4/U6 unwinding and U2/U6 
unwinding in vitro (Small, Leggett et al. 2006). Finally, inter-domain movement is likely 
important. Large Snu114 conformational changes could facilitate such transitions as the 
release of tri-snRNP proteins during activation, and the integration of U5 snRNP in the 
U5.U4/U6 tri-snRNP. Besides what has been inferred about Snu114/Cwf10 from its 
homology to EF2, Snu114 is known to function in both spliceosome activation and 
disassembly (Bartels, Klatt et al. 2002, Brenner and Guthrie 2006, Small, Leggett et al. 
2006), and its presence is required for the integrity of the U5 snRNP and tri-snRNP 
(Bartels, Klatt et al. 2002, Brenner and Guthrie 2006). Additionally, several studies 
implicate Snu114 in the second step of catalysis (Fabrizio, Laggerbauer et al. 1997, Liu, 
Laggerbauer et al. 1997, Frazer, Lovell et al. 2009). Thus, Snu114/Cwf10 is important 
throughout the splice cycle; unfortunately its mechanisms beyond nucleotide binding are 
elusive. A spliceosome protein that may act as a guanine nucleotide exchange factor 
(GEF) is unknown. Additionally, the local movements Snu114 may drive with its 
neighboring proteins and RNAs are completely unknown. Finally, the ways in which 
GTP binding, relative domain movement, and NTE coupling to the EF2-like domains 
influence each other and how much they each contribute to the protein’s functions are 
unknown. 
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 Summary 
A testament to the process’s complexity, spliceosome-catalyzed splicing is still 
not well understood in several respects after over three decades of research. While the 
molecular players – the structural RNAs and proteins – are well-catalogued, we have only 
an intermediate understanding of the post-translational modifications important for 
splicing and the functions of the individual components. Knowledge is perhaps most 
lacking in the mechanisms involved in each spliceosome transition, and, relatedly, the 
spatial organization of the complex at multiple intermediate stages. In this work, I have 
manipulated S. pombe Cwf10, the sole spliceosomal GTPase, to examine its functions 
and how its mutation influences splicing complexes. In chapter II, I will characterize the 
NTE domain of Cwf10, and in chapter III, I will characterize ts cwf10 mutants generated 
to improve homogeneity of splicing complexes for structural characterization. 
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Introduction 
The spliceosome is composed of several structural RNAs and dozens of protein 
components which undergo an amazing procession of changes during the course of one 
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splice cycle (reviewed in Will and Lührmann 2011). Snu114/Cwf10 is a member of the 
U5 snRNP, contains a GTPase domain, and functions during multiple spliceosome 
transitions (Fabrizio, Laggerbauer et al. 1997, Achsel, Ahrens et al. 1998, Bartels, Klatt et 
al. 2002, Ohi, Link et al. 2002, Brenner and Guthrie 2006, Small, Leggett et al. 2006). 
The Snu114 family of proteins shares homology with the eukaryotic translation 
elongation factor EF2 (Fabrizio, Laggerbauer et al. 1997) but differs significantly from 
EF2 in that they contain a conserved N-terminal extension (NTE) (Figure 2-1A). The 
NTE is approximately 120 amino acids long and is rich in acidic residues, with 39% of 
the first 56 residues being aspartate or glutamate in Schizosaccharomyces pombe Cwf10 
(Figure 2-1B). The human and S. pombe NTEs are 43% identical, a much larger 
percentage than the human and Saccharomyces cerevisiae NTEs (26% identical), 
suggesting that studies in S. pombe may also yield relevant insights into the activity of the 
human NTE. 
Functional data implicate the NTE in spliceosome activation and catalysis; 
however, very little is known about the structure and binding partners of the NTE. In 
human in vitro splicing assays, addition of antibodies against the U5-116K NTE partially 
blocks the second step of splicing (Fabrizio, Laggerbauer et al. 1997). Removal of Sc 
Snu114’s NTE (Sc snu114∆N) causes a temperature sensitive (ts) phenotype in vivo, 
while in vitro splicing extracts prepared from Sc snu114∆N cells are unable to efficiently 
unwind the U4/U6 snRNAs prior to the first catalytic step of pre-mRNA splicing (Bartels, 
Klatt et al. 2002). These extracts also contain destabilized U5 snRNPs (Bartels, Klatt et al. 
2002). Finally, the Sc snu114∆N allele shows synthetic lethal and synthetic sick 
interactions with mutations in the U5 snRNA loops 1 and IL1, as well as with U6 snRNA 
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FIGURE 2-1
The N-terminal extension is conserved in Snu114/Cwf10 family members
A) Domain map of S. pombe Cwf10, as defined by three-dimensional modeling (MODELLER;
Sali and Blundell, 1993) of S. pombe Cwf10 on to the crystal structure of S. cerevisiae EF2 (PDB
1N0V). Domains are named as defined by homology with EF2 and residue numbers listed above
domains refer to S. pombe Cwf10. The NTE domain is not present in EF2. B) CLUSTALW
(Thompson et al., 1994) sequence alignment of the N-termini of Snu114/Cwf10 homologs.
Residues that are identical in at least three of the five homologs are in bold. Clusters of identical
residues are highlighted in gray. N-terminal boundaries of the various Cwf10 truncations and the 
S. cerevisiae Snu114∆N truncation are noted above the alignment. “*” identical, “:” similar. Arrow
marks the transition from the NTE to EF2-like domain I, as assigned in A.
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alleles that disrupt U2/U6 base pairing (Frazer, Lovell et al. 2009). These results led the 
authors to speculate that the Sc Snu114 NTE may be involved in facilitating U5 and U6 
snRNA interactions near the 5’ splice site. Interestingly, no physical interactions have 
been determined for the NTE in any organism, leaving open the question of how the NTE 
is spatially oriented within the spliceosome. Additionally, the only structural information 
about the NTE is a bioinformatics prediction that the NTE of human U5-116K is 
composed of two disordered regions of equal length (Korneta, Magnus et al. 2012). 
 In this study we characterize the S. pombe Cwf10 NTE both in vivo and 
biochemically. We show that although the NTE is not essential in S. pombe, deleting this 
region leads to a general splicing defect at all temperatures. We define a small region of 
the NTE required for efficient splicing and demonstrate the presence of both structural 
order and disorder within the NTE. Finally, we show that when the NTE is overexpressed 
in vivo it stably associates with a protein complex similar to the S. pombe U5.U2/U6 
spliceosomal complex, and rescues the splicing defect caused by deletion of the NTE 
from endogenous cwf10+. Taken together, these findings suggest that the NTE is a semi-
ordered domain that has the ability to function in trans to the EF2-like portion of Cwf10.  
 
Results 
 
Deleting the Sp Cwf10 NTE impairs splicing in vivo 
To more closely examine the in vivo role of the Cwf10 NTE in pre-mRNA 
splicing, we prepared an S. pombe cwf10 construct corresponding to S. cerevisiae 
snu114ΔN (Bartels, Klatt et al. 2002). Although cwf10 2-135Δ aligns with snu114ΔN 
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(Figure 2-1B), the S. pombe allele did not support growth at either 25°C or 32°C when 
integrated at the endogenous locus (data not shown), while the S. cerevisiae allele is 
viable at temperatures below 40°C (Frazer, Lovell et al. 2009). Upon closer examination 
of the alignment of Snu114 family members with EF2, it appears that Cwf10 2-135Δ 
lacks residues corresponding to domain I (Figure 2-1B) that may affect the folding of this 
essential domain. Therefore, we deleted eight fewer amino acids and successfully 
integrated cwf10 2-127Δ (hereafter cwf10-ΔNTE) at the endogenous locus. This result 
suggests that some of the defects seen in the S. cerevisiae snu114ΔN strain may partially 
result from a defect in the folding of domain I of the EF2-like region of Snu114. 
We further characterized cwf10-ΔNTE to examine the NTE’s contribution to in 
vivo splicing. The cwf10-ΔNTE strain formed slightly smaller colonies on solid media at 
all temperatures tested (Figure 2-2A) and exhibited slow growth in liquid culture at 25°C 
and 36°C compared with wild-type cells (Figure 2-2B and data not shown). Conversely, 
overexpression of the NTE (cwf10 1-135 or 1-107) under the high-strength nmt (no 
message in thiamine) promoter did not impair cell viability, indicating its expression is 
not dominant negative (data not shown). RT-PCR analysis of tbp1_a, an mRNA intron 
highly sensitive to splicing defects (Habara, Urushiyama et al. 2001), indicated that 
cwf10-ΔNTE cells grown at 25°C accumulate unspliced transcript (Figure 2-2C). Thus, 
removal of the Cwf10 NTE reduces splicing efficiency in vivo. 
In our experience, yeast spliceosome mutants often have a lower steady-state 
mutant protein level which correlates with the splicing defect. To determine whether the 
deletion of the Cwf10 NTE simply decreases the amount of Cwf10 in cells, thus reducing 
splicing efficiency, antibodies were generated against Cwf10 amino acid residues 673-
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Characterization of the S. pombe cwf10-∆NTE allele
A) Growth of serial dilutions of wild-type (cwf10+) and cwf10-∆NTE. Serial dilutions of equal 
numbers of cells were spotted on solid YE media and grown at 18°C, 25°C, 32°C, and 36°C. B) 
Growth of cwf10+ and cwf10-∆NTE cells in liquid YE at 25°C.  Samples were collected at 2 hour 
intervals to determine cell number. C) The NTE is required for efficient pre-mRNA splicing. RT-
PCR was used to characterize RNA extracted from cwf10+ and cwf10-∆NTE cells. Total RNA was 
isolated from cells grown at 25°C. RT-PCR was performed with random hexamer primers. 
Portions of the tbp1 (containing introns) and act1 (intronless) transcripts were amplified from the 
RT-PCR products. Mature (m) and pre-mRNA (p) forms are labeled. No bands were detected in 
any RT-PCR samples in which the reverse transcriptase enzyme was omitted (-RT). D-H) 
Immunoblots demonstrating relative protein levels of pre-mRNA splicing factors in either cwf10+ 
or cwf10-∆NTE backgrounds. “*” marks the position of each protein on the blot. D-E) Lysates 
from cwf10+ and cwf10-∆NTE cells were probed with anti-PSTAIR and either anti-Cwf10 (D) and 
anti-Cdc5 (E) antibodies. F) Lysates from brr2-HA and brr2-HA cwf10-∆NTE cells probed with 
anti-HA and anti-PSTAIR. G) Lysates from prp1-myc and prp1-myc cwf10-∆NTE cells probed with 
anti-myc and anti-PSTAIR. H) Lysates from prp3-V5 and prp3-V5 cwf10-∆NTE cells probed with 
anti-V5 and anti-PSTAIR. Anti-PSTAIR detects Cdc2. Numbers to the left of each blot indicate 
molecular weight in kilodaltons. I) Comparison of protein levels of each pre-mRNA splicing factor 
in cwf10-∆NTE cell lysates relative to the cwf10+ value (100%), normalized to Cdc2, quantitated 
from Western analysis. Values were calculated using three biological replicates. Error bars 
indicate standard error of the mean. The P value was determined using the Student’s t test. 
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*
FIGURE 2-2
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983 (domains IV and V). Immunoblotting of S. pombe lysate with α-Cwf10 antiserum 
detected a single protein at the anticipated molecular weight of ~116 kDa (Figure 2-2D, 
cwf10+ lane). In cwf10-ΔNTE lysates the antiserum detected a band ~20 kDa smaller than 
the wild-type protein, consistent with the predicted molecular weight of the deletion 
(Figure 2-2D). Using quantitative Western blotting, we found that levels of Cwf10 were 
consistently higher in cwf10-ΔNTE cells than in wild-type cells when quantified against 
the loading control Cdc2 (Cdk1) (Figure 2-2I). These results show that low levels of 
Cwf10 do not cause the splicing defect in cwf10-∆NTE cells. To examine whether levels 
of other splicing components might be affected in this background, we analyzed the 
protein levels of S. pombe Cdc5 (homolog of S. cerevisiae Cef1) (Figure 2-2E), a core 
component of the nineteen complex (NTC) (Tsai, Chow et al. 1999, Ohi and Gould 2002), 
Brr2 (homolog of S. cerevisiae Brr2) (Figure 2-2F), a core U5 snRNP member (Achsel, 
Ahrens et al. 1998), as well as Prp1 (homolog of S. cerevisiae Prp6) and Prp3 (homolog 
of S. cerevisiae Prp3) (Figure 2-2G and H), both members of the U4/U6/U5 tri-snRNP 
and B-complex (Stevens and Abelson 1999, Fabrizio, Dannenberg et al. 2009). In the 
cwf10-ΔNTE background, levels of Brr2 and Prp3 were similar to levels seen in wild-type 
cells; however, both Cdc5 and Prp1 levels were reduced to ~70% and ~65%, respectively 
(Figure 2-2I). Since the prp1 transcript does not contain introns, we attribute the lower 
level of these proteins to reduced protein stability rather than a general reduction in 
transcript levels.  
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RNA-seq demonstrates a general splicing defect in cwf10-ΔNTE cells 
Previously it has been demonstrated that mutations in core spliceosome proteins 
affect splicing of introns to different degrees (Romfo, Lakhe-Reddy et al. 1999, Pleiss, 
Whitworth et al. 2007, Sridharan, Heimiller et al. 2011). That is, one mutant can have a 
profile of inefficiently spliced introns that is significantly different from the profile of 
another mutant. To examine the extent of splicing changes in cwf10-ΔNTE cells, we 
performed transcriptome analysis. RNA was extracted from cwf10+ and cwf10-ΔNTE 
cells grown at 25°C, and two replicates for each genetic background were sequenced on 
the Illumina HiSeq platform. Two methods were employed to evaluate the effect of NTE 
deletion on splicing efficiency using the RNA sequencing data. A Cochran-Mantel-
Haenszel (CMH) test assessed the significance of the change in the ratio of spliced to 
unspliced transcripts between cwf10-ΔNTE and cwf10+ (Materials and Methods), while 
DESeq (Anders and Huber 2010) revealed differentially expressed introns between the 
two conditions. Splicing efficiency displayed a nearly-global shift when cwf10-ΔNTE and 
cwf10+ were compared; this can be seen as a shift of most points toward the right of the 
diagonal in Figure 2-3A. Splicing efficiency was highly reproducible between replicates, 
with a tight distribution along the diagonal (Figure 2-4). This suggests an extensive 
splicing defect in the NTE-deleted strain that affected most introns. Using the splicing 
efficiency (SE) approach under a stringent threshold (q-value <0.05; fold-change >2), we 
identified 1,193 introns (out of 5,361 possible introns) whose splicing efficiency was 
significantly compromised in the mutant. Similarly, using DESeq, 883 introns were more 
highly expressed in cwf10-ΔNTE relative to cwf10+, indicating that their splicing was 
significantly less efficient in the mutant strain (adjusted p-value <0.05 and fold-change 
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FIGURE 2-3
RNA-seq data reveal a nearly-global splicing defect in cwf10-∆NTE cells 
A) A global reduction in splicing efficiency in the cwf10-∆NTE strain (Y-axis; log2 scale) compared to wild-type 
(X-axis; log2 scale). Each point represents an intron (5,361 in total), while red dots represent the 1,193 
introns for which splicing efficiency was significantly compromised in the mutant compared to wild-type 
(CMH test, q-value <0.05, absolute fold change cutoff >2). Note that this graph compares one replicate of 
each genotype. B) Differentially expressed genes (blue) and introns (red) identified by DESeq (adjusted p-
value <0.05 and absolute fold-change >2; X-axis: normalized mean expression; Y-axis log2 fold-change). A 
total of 21,193 genes were interrogated, of which 883 introns were up-regulated in the mutant. (C) Venn 
Diagram illustrating the overlap between the two methods used to assess the extent of the splicing defect 
(SE-light blue; DESeq-light pink). The probability of observing the same number of overlaps or more by 
chance assuming a hypergeometric distribution was determined by “phyper” function in R. (D) Top panel:  
The proportion of significant and non-significant introns within a given intron-length bin (2,352 introns 
identified by SE or DESeq, with q-value or adjusted p-value <0.05, respectively; for a given intron, splicing 
efficiency was compromised in both replicates; light grey: significant; dark grey: non-significant; exact 
number are as indicated). Bottom panel: The splicing efficiency of the significant intron set as a function of 
their length (straight and dashed lines with circles: technical replicates of wild-type; straight and dashed 
lines with diamonds: technical replicates of mutant; line with X’s: mean log10 of SE fold-change 
mutant/wild-type).
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Figure 3. RNA-seq data reveal a global splicing defect in cwf10-∆NTE cells.  (A) A global reduction in 
splicing efficiency in the cwf10-∆NTE strain (Y-axis; log2 scale) compared to wild-type (X-axis; log2 scale). 
Each point represents a  i tron (5,361 in total), while red dots represent the 1,193 introns for which splic-
ing efficiency was significantly compromised in the mutant compared to wild type (CMH test, q-value <0.05, 
absolute fold change cutoff >2). Note that th s graph compa es one replicate of each geno ype. (B) Differ-
entially expre sed gen s (blue) and intr ns (red) identified by DESeq (adjusted p-valu  <0.05 and absolute 
fold-change >2; X-axis: normalized mean expression; Y-axis log2 fold-change). A total of 21,193 genes 
were interrogated, of which 883 introns were up-regulated in the mutant. (C) Venn Diagram illustrating the 
overlap between the two methods used to assess the extent of the splicing defect (SE-light blue; 
DESeq-light pink). The probability of observing the same number of overlaps or more by chance assuming 
a hypergeometric distribution was determined by “phyper” function in R. (D) Top panel:  The proportion of 
significant and non-significant introns within a given intron-length bin (2,352 introns identified by SE or 
DESeq, with q-value or adjusted p-value <0.05, respectively; for a given intron, splicing efficiency was 
compromised in both replicates; light grey: significant; dark grey: non-significant; exact number are as 
indicated). Bottom panel: The splicing efficiency of the significant intron set as a function of their length 
(straig t and dashed lines with circles: biologi al r plicates of wild-type; straight and das ed lines with 
diamonds: b ological replicates of mutan ; line with X’s: mean log10 of SE fold-change mutant/wildtype).
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FIGURE 2-4
Reproducibility of splicing efficiency in replicates 
Each point represents an intron (5,361 in total; ‘r’ Pearson’s correlation coefficient; log2 scale). 
A) Two wild-type replicates. B) Two cwf10-∆NTE replicates.
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>2; Figure 2-3B). There was a good correspondence between the two methods (p <2.2e-
226, hypergeometric test; Figure 2-3C), which was even stronger when no fold-change 
cutoff was applied (p <2.7e-249; data not shown). Overall, the splicing of 2,352 introns 
(approximately 44% of all introns) was significantly compromised by the NTE deletion, 
as indicated by at least one method without the fold-change cutoff. The effect of the NTE 
deletion was not dependent on intron length, and neither was the magnitude of the 
reduction in splicing efficiency (Figure 2-3D, top and bottom panels, respectively). 
Moreover, the effect of the mutation was not dependent on intron GC content, branch-site 
sequence, 5’ intron sequence, or on the position of the intron within the transcript (data 
not shown). For a small set of introns (17 total), splicing efficiency was significantly 
improved by the deletion, but there was no agreement between the two methods under 
these criteria (14 found by DESeq and 3 by SE). However, when the magnitude of the 
fold-change was ignored, the splicing efficiency of 223 introns was significantly 
improved (209 by DESeq and 24 by SE, of which ten were identified by both methods; p 
< 3.9e-10). We did not find any clear sequence features that could explain why a small 
percentage of introns were either spliced with the same or better efficiency in the NTE 
deletion background. Taken together, the RNA-seq data indicate that the NTE of Cwf10 
is required for efficient splicing of most S. pombe introns. 
 
The lack of Cwf10-NTE changes spliceosome sedimentation patterns 
In in vitro splicing assays, deletion of the Sc Snu114 NTE inhibits U4/U6 snRNA 
unwinding, thus impairing activation of the spliceosome (Bartels, Klatt et al. 2002). Since 
S. pombe does not have a robust in vitro splicing extract system, likely due to the stability 
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of the U5.U2/U6 spliceosomal complex (Huang, Vilardell et al. 2002, Ohi, Ren et al. 
2007), we could not directly test whether Sp Cwf10-NTE plays a similar role in fission 
yeast. However, we postulated that if the S. pombe Cwf10-NTE shares a similar function 
to its S. cerevisiae ortholog, cells that lack the Cwf10-NTE might have altered 
sedimentation patterns of spliceosomal complexes and/or snRNAs. Thus, to test the effect 
of deleting Cwf10-NTE in vivo, we compared the sedimentation patterns of Cwf10, Cdc5 
(Sc Cef1), and the five snRNAs in sucrose gradients using native lysates made from 
either wild-type or cwf10∆-NTE cells (Figure 2-5). It has been previously shown that in 
lysates from asynchronously growing wild-type S. pombe cells, the majority of 
spliceosomes sediment as a stable ~37S U5.U2/U6 complex (McDonald, Ohi et al. 1999, 
Huang, Vilardell et al. 2002, Ohi, Link et al. 2002, Ohi, Ren et al. 2007), although less 
abundant U5/U6/U4/U2/U1 and U5/U6/U4/U2 complexes have also been characterized 
(Carnahan, Feoktistova et al. 2005, Lützelberger, Bottner et al. 2009). Unlike what is 
found in other organisms, S. pombe lysates lack detectable quantities of a pre-assembled 
U5.U4/U6 tri-snRNP (Huang, Vilardell et al. 2002).  
As expected, in wild-type lysates a majority of Cwf10 sediments at an ~37S peak 
corresponding to the sedimentation pattern of the U5.U2/U6 complex (Figure 2-5A and B, 
fraction 9, (Ohi, Link et al. 2002)); however, the sedimentation pattern of Cwf10-∆NTE 
in cwf10-∆NTE lysates changes, with a portion of Cwf10-∆NTE shifting to higher 
molecular mass fractions (Figure 2-5A and B, fractions 11 and 12). The sedimentation 
pattern of Cdc5, a core NTC component, does not appear grossly altered in lysates from 
cwf10-∆NTE cells (Figure 2-5C and D). We next compared the sedimentation profiles of 
spliceosomal snRNAs in both wild-type and cwf10-∆NTE lysates. As expected in the 
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FIGURE 2-5 (from previous page)
Sedimentation of spliceosome components is altered in cwf10-ΔNTE cells 
Lysates from cwf10+ and cwf10-∆NTE cells grown at 25°C were run on 10-30% sucrose gradients. 
Fractions were collected and either TCA precipitated for immunoblot analysis or RNA was 
extracted for Northern analysis. A and C) Immunoblots of fractions collected from 10-30% 
sucrose gradients of lysates from cwf10+ prp1-myc and cwf10-∆NTE prp1-myc using anti-Cwf10 
(A) and anti-Cdc5 (C). B and D) Intensities of the bands of the anti-Cwf10 blot (B) and anti-Cdc5 
(D) were quantified and plotted as a percentage of the sum of the signal from all fractions. The 
bands were quantified by near infrared detection and Odyssey software (Licor). E, G, I, K, and M) 
RNA was isolated from fractions collected from 10-30% sucrose gradients of cwf10+ and 
cwf10-∆NTE lysates. Blots were probed with 32P-labeled oligonucleotides complementary to the 
S. pombe U2 (E), U5 (G), U6 (I), U1 (K), and U4 (M) snRNAs. F, H, J, L, and N) Intensities of the 
bands of the U2 (F), U5 (H), U6 (J), U1 (L), U4 (N) probes were quantified and plotted as a 
percentage of the sum of the signal from all fractions. The bands were quantified by phosphor-
imaging and ImageQuant TL 8.1 software (GE Healthcare). The “*” in H and L highlights the 
peak of the U5 and U1 snRNAs found in a small molecular weight fraction in cwf10-∆NTE. 
Column I indicates where the U5.U2/U6 spliceosomal complex sediments in the gradients. The 
migration of FAS (40S), thyroglobulin (19S), and catalase (11.3S) collected from parallel 
gradients is indicated. 
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wild-type background, the U2, U5, and U6 snRNAs co-sedimented at ~37S as described 
before (McDonald, Ohi et al. 1999, Huang, Vilardell et al. 2002, Ohi, Link et al. 2002, 
Ohi, Ren et al. 2007) (Figure 2-5 E-J). The sedimentation pattern of U4, U5, and U6 
snRNAs from wild-type cells (Figure 2-5 G-J and M-N) are consistent with previous 
reports that S. pombe appears to lack an independently sedimenting U5.U4/U6 tri-snRNP 
(Huang, Vilardell et al. 2002). Another apparent difference between fission yeast and 
other organisms is the abundance of the U2 snRNP at 12S (Figure 2-5E and F), which 
most likely represents the core U2 snRNP rather than the larger 17S complex that 
contains the SF3a and SF3b sub-complexes (Behrens, Galisson et al. 1993, Behrens, Tyc 
et al. 1993, Brosi, Hauri et al. 1993, Pauling, McPheeters et al. 2000). However, when 
comparing wild-type and cwf10-∆NTE lysates, the sedimentation patterns of all the 
snRNAs were altered to some degree (Figure 2-5 E-N). The differences include a small 
but consistent shift of the U2, U4, U5, and U6 snRNAs to higher molecular mass 
fractions (>40S, fractions 11-13, Figure 2-5 E-J and M-N), as well as, increases in the 
amount of the U5 and U1 snRNAs at lower molecular mass fractions (<11.3S, Figure 2-5 
G-H and K-L). Thus, from these analyses we conclude that deleting the Sp Cwf10 NTE 
does alter the distribution of spliceosomal complexes in vivo, although in a complex 
pattern with shifts to both higher and lower molecular masses. 
 
cwf10-ΔNTE synthetically interacts with factors predicted to be involved in 
spliceosome activation 
 As another approach to investigate whether S. pombe NTE function can be 
correlated to a specific step of the pre-mRNA splicing reaction or stage of spliceosomal 
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organization, we tested for genetic interactions between cwf10-∆NTE and eight 
previously characterized S. pombe pre-mRNA splicing alleles (Figure 2-6). Our analysis 
revealed that cwf10-ΔNTE is synthetic lethal when combined with prp1-4 (Urushiyama, 
Tani et al. 1996) (homolog of S. cerevisiae PRP6), spp42-1 (Schmidt, Richert et al. 1999) 
(homolog of Sc PRP8), and cdc5-120 (Nurse, Thuriaux et al. 1976) (homolog of Sc 
CEF1). cwf10-∆NTE has an extreme synthetic sick phenotype in combination with 
prp17∆ (Sapra, Arava et al. 2004). When cwf10-∆NTE is combined with either prp4-73 
(Rosenberg, Alahari et al. 1991) (homolog of human PRPF4B) or spp41-1 (Schmidt, 
Richert et al. 1999) (homolog of Sc BRR2), the cells are synthetically sick. Conversely, 
synthetic interactions are weak or non-existent between cwf10-ΔNTE and aar2∆ (Kim, 
Hayles et al. 2010) (homolog of Sc AAR2), prp10-1 (Urushiyama, Tani et al. 1996) 
(homolog of Sc HSH155), or cdc28-P8 (Nasmyth and Nurse 1981) (homolog of Sc 
PRP2). Two of the three synthetic lethal interactions, prp1-4 and spp42-1, are with genes 
previously shown to be important for spliceosome activation (Kuhn, Li et al. 1999, 
Lützelberger, Bottner et al. 2009). The third synthetic lethal interaction, cdc5-120, is 
interesting because Cdc5 is likely involved in spliceosome activation as a component of 
the NTC (Chan, Kao et al. 2003) and in modulating the transition between first and 
second step catalysis (Query and Konarska 2012). The most obvious synthetic sick 
phenotype is in combination with deletion of prp17, a second catalytic step factor (Jones, 
Frank et al. 1995). We conclude that the S. pombe Cwf10 NTE is likely important for a 
specific stage in spliceosome activation, and possibly also for a later stage(s) in the 
splicing reaction. 
            35
25°C
36°C
32°C
cw
f1
0 
∆N
TE
cw
f1
0+
cw
f1
0 
∆N
TE
 c
dc
28
-P
8
cd
c2
8-
P
8
cw
f1
0 
∆N
TE
 p
rp
10
-1
pr
p1
0-
1
cw
f1
0 
∆N
TE
 p
rp
4-
73
pr
p4
-7
3
cw
f1
0 
∆N
TE
cw
f1
0 
∆N
TE
 s
pp
41
-1
sp
p4
1-
1
cw
f1
0 
∆N
TE
 a
ar
2∆
aa
r2
∆
A
prp4-73
prp1-4
spp42-1
cdc5-120
cdc28-P8
aar2∆
spp41-1
Synthetic
Lethal
No
Yes
Yes
Yes
No
No
No
homolog
hPRPF4B
Sc Prp6
Sc Prp8
Sc Cef1
Sc Prp2
Sc Aar2
Sc Brr2
Spliceosomal
Complex
Kinase
U5 snRNP
U5 snRNP
NTC
Bact complex
U5 snRNP
U5 snRNP
Growth
25˚C
-/+
-
-
-
+
+
-/+
36˚C
-
-
-
-
prp10-1 No Sc Hsh155 U2 snRNP+ -
-
-/+
-/+
- = does not grow -/+ = slow growth compared
          to single mutant
+ = grows
cwf10-∆NTE
crossed with:
cw
f1
0 
∆N
TE
cw
f1
0 
∆N
TE
 p
rp
17
∆
pr
p1
7∆
prp17∆ No Sc Prp17 NTC-/+ -/+
Genetic interactions of cwf10-ΔNTE with alleles of other pre-mRNA splicing factors
A) Serial dilutions of single and double mutants grown at 25°C, 32°C, and 36°C were used to 
examine growth. B) Table summarizing results of crossing cwf10-ΔNTE with other pre-mRNA 
splicing factor mutants. The column labeled “Growth” indicates growth of the double mutant 
compared with the single mutant allele in a wild-type (cwf10+) background at 25°C and 36°C. 
“-“ = no growth, “-/+” = slow growth, “+” = growth, “Sc” = S. cerevisiae; “h” = human.
FIGURE 2-6
B
            36
 To further address whether the NTE may be involved in facilitating the transition 
from an inactive to activated spliceosome, we attempted to analyze the protein 
composition of spliceosomal complexes purified from either a cwf10-∆NTE or wild-type 
background. Purification of tagged Cwf10 was our first choice, due to changes in 
sedimentation of this protein in wild-type and mutant backgrounds (Figure 2-5A and B). 
However, we were not able to tag endogenous cwf10-∆NTE with a C-terminal TAP tag.  
Purification of the Prp1-TAP complex, which is associated with a group of proteins 
similar to Complex B (Carnahan, Feoktistova et al. 2005), failed due to extremely low 
levels of the Prp1-TAP fusion protein in cwf10-∆NTE prp1-TAP lysates. Therefore, we 
purified a 
U5.U2/U6 spliceosomal complex from cdc5-TAP cells in either a cwf10-∆NTE or wild-
type background at 75 mM salt and identified associating proteins using one-dimensional 
(1D) liquid chromatography-tandem mass spectrometry (LC-MS/MS). Cdc5 sedimented 
similarly in the wild-type and mutant cwf10 backgrounds (Figure 2-5C and D), but we 
reasoned that using lower salt (75 mM) in the purification would preserve weaker 
interactions that may be unique to one of the two backgrounds. From analysis of peptides 
in two biological replicates of each genetic background, the U5.U2/U6 complex appeared 
largely similar in cwf10+ and cwf10-∆NTE (Table 2-1), suggesting that, although Cwf10 
is highly represented in the U5.U2/U6 complex, the NTE domain is not required to 
maintain most associations within that complex. 
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S. pombe 
 
ORF number 
Cdc5-TAP  
S. cerevisiae 
 
H. sapiens cwf10-∆NTE wild-type 
I II I II 
 
 
 
Core 
snRNP 
Smb1 SPAC26A3.08 3 2 12 11 Smb1 SMB/B’ 
Smd1 SPAC27D7.07c 4 3 8 8 Smd1 SMD1 
Smd2 SPAC2C4.03c 5 6 14 13 Smd2 SMD2 
Smd3 SPBC19C2.14 --- 3 5 14 Smd3 SMD3 
Sme1 SPBC11G11.06c 2 1 6 4 Sme1 SME1 
Smf1 SPBC3E7.14 5 8 6 10 Smf1 SMF1 
Smg1 SPBC4B4.05 1 3 10 8 Smg2 SMG1 
 
 
 
U2 
Lea1 SPBC1861.08c 11 11 28 27 Lea1 U2A’ 
Msl1 SPBC8D2.09c 3 2 2 6 Msl1 U2B” 
Prp2/Mis11 SPBC146.07 --- --- --- 4 Mud2 U2AF65 
Sap61 SPBC36.09 3 2 2 3 Prp9 SF3A60 
Sap114 SPAC22A12.09c 1 1 1 3 Prp21 SF3A1 
Ini1 SPAC23H3.02c --- --- 1 2 Rds3 SF3b14b 
Sap145 SPAC22F8.10c --- 2 1 1 Cus1 SF3B150 
Prp10 SPAC27F1.09c 3 2 3 8 Hsh155 SF3B160 
Prp12 SPAPJ698.03c 6 9 5 3 Rse1 SF3B130 
 
 
U5 
Cwf10-ΔNTE SPBC215.12 34 37 --- --- Snu114 U5-116 
Cwf10 SPBC215.12 --- --- 100 73 Snu114 U5-116 
Brr2 SPAC9.03c --- --- 4 11 Brr2 U5-200 
Spp42 SPAC4F8.12c 59 78 186 171 Prp8 U5-220 
Cwf17/Spf38 SPBC1289.11 14 14 41 38 UNK U5-40 
 
 
 
NTC core 
Cdc5 SPAC644.12 31 29 92 71 Cef1 CDC5 
Cwf2 SPAC3A12.11c 5 7 37 38 Cwc2 RBM22 
Cwf7 SPBC28F2.04c 10 14 34 13 Snt309 SPF27 
Cwf15 SPBC337.06c 2 3 13 11 Cwc15 AD002 
Prp5 SPBP22H7.07 19 19 51 57 Prp46 PRL1 
Prp19 SPAC29A4.08c 25 24 75 48 Prp19 PRP19 
 
 
NTC-
associated 
Cwf3 SPBC211.02c 23 29 47 56 Syf1 SYF1 
Cwf4 SPBC31F10.11c 18 23 67 48 Clf1 CRN1 
Cwf5/Ecm2 SPCC550.02c 12 17 52 42 Ecm2/Slt11 RBM22 
Cwf12 SPBC32F12.05c 6 3 16 12 Isy1 ISY1 
Prp45 SPCC188.11 13 19 28 30 Prp45 SKIP 
Prp17 SPBC6B1.10 14 14 38 45 Prp17 hPRP17 
Syf2 SPBC3E7.13c 6 10 19 25 Syf2 SYF2 
 
 
 
 
 
 
Other 
Cwf11 SPBC646.02 34 37 115 97 UNK hCWF11 
Cwf14 SPBC24C6.11 7 9 16 13 Cwc14 G10 
Cwf16 SPAC9.13c 2 3 1 8 Yju2 CCDC94 
Cwf18 SPCP1E11.07c 7 6 12 13 UNK MGC23918 
Cwf19 SPAC30D11.09 18 16 37 47 UNK hCWF19L2 
Cwf21 SPAC4A8.09c 3 1 6 7 Cwc21 SRm300 
Cwf22 SPBC13E7.01 7 9 15 18 Cwc22 hCWC22 
Cwf25 SPBC146.05c --- 1 --- 10 Cwc25 hCWF25 
Cwf26 SPCC1620.10 1 1 3 1 Bud13 BUD13 
Cyp1 SPAC57A10.03 4 3 7 7 UNK PPIL1 
Mug161 SPAC1F3.09 --- --- 8 9 YGR093W CWF19L1 
Prp16 SPBC1711.17 --- --- --- 6 Prp16 PRP16 
Cdc28 SPBC19C2.01 --- --- --- 5 Prp2 DHX16 
Prp43 SPBC16H5.10c --- --- 9 2 Prp43 hPRP43 
Prp22 SPAC10F6.02c --- 3 13 21 Prp22 hPRP22 
Saf4 SPBC18H10.10c 1 3 11 11 UNK CCDC130 
Prp40/Usp104 SPAC4D7.13 1 1 --- 3 Prp40 PRPF40A 
Usp105 SPBC4B4.09 1 1 2 1 Prp39 UNK 
Bpb1 SPCC962.06c 1 --- --- 4 Msl5 SF1 
Rsd1 SPAC19G12.07c 4 3 --- 11 UNK RNPC2 
Srp1 SPAC29A4.06c --- --- 1 2 UNK SRFS2 
Dsk1 SPBC530.14c --- --- 5 5 Sky1 SRPK1 
Srp2 SPAC16.02c 2 ---- 1 7 Npl3 UNK 
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Table 2-1. Splicing proteins co-purifying with Cdc5-TAP in either a cwf10-∆NTE or wild-type background 
using 75 mM NaCl. Two biological replicates were analyzed using one-dimensional (1D) liquid 
chromatography-tandem mass spectrometry (LC-MS/MS) per genotype (I and II). Peptide counts are 
included for each replicate. UNK indicates that an ortholog is unknown or not present. “---“, no peptides 
identified. 
 
 
 
Sum3 SPCC1795.11 3 1 1 4 Ded1 DDX3 
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The Cwf10 NTE is partially folded, but contains regions of disordered coiled-coil 
The structural characteristics of the NTE were of interest to us for several reasons. 
First, the only published data on NTE structure is a bioinformatics predication that the 
region is unfolded (Korneta, Magnus et al. 2012). Second, the NTE does not carry strong 
homology to known protein domains or to primary sequences in other proteins (data not 
shown). To more carefully examine the structural characteristics of this domain, we used 
DISOPRED (Ward, McGuffin et al. 2004), a program that predicts structure disorder, to 
precisely map potential regions of intrinsic disorder in the Cwf10 NTE. This analysis 
showed that a majority of the first N-terminal 60 amino acids are strongly predicted to 
lack secondary structure. The C-terminal 75 amino acids are predicted to be structurally 
ordered (Figure 2-7A), perhaps as β-strands as suggested by analysis with PSIPRED 
version 3.3 (Jones 1999, Bryson, McGuffin et al. 2005), a program that predicts 
secondary structure (data not shown). To experimentally test this model we expressed 
and purified recombinant Cwf10(1-135)His6 from E. coli (Figure 2-8A). Analysis by 
sedimentation analytical ultracentrifugation (SVAU) shows that the Cwf10 NTE 
sediments as a monomer (s = 0.8, predicted molecular mass of ~19 kDa, rsmd = 0.09) 
with a frictional ratio of 2.13 (Figure 2-7B). Cwf10(1-135)His6 was then analyzed by 
circular dichroism (CD) spectrometry using near UV wavelengths, which can be used to 
detect tertiary structure. Analysis of this spectrum shows a strong signal between 260-290 
nm, suggesting that there are some aromatic residues found in a folded environment 
(Figure 2-7C). As expected, this signal is no longer seen when the protein is completely 
denatured in 6 M guanidine-HCl (Figure 2-7D). The NTE contains six tyrosines, two in 
the first 12 amino acids and the remaining four between residues 78 and 125 (Figure 2-
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FIGURE 2-7
Biophysical characterization shows the Cwf10 NTE contains regions of order and disorder
A) Residues 18-61 of the NTE are predicted to be intrinsically disordered in solution using DISOPRED 
(Ward, et al., 2004), a program that predicts structure disorder. The false positive rate (FPR) was set at 5%. 
B) Cwf10(1-135)His6 is monomeric by SVAU. The calculated s [c(s)] is plotted versus the sedimentation 
coefficient (s) for Cwf10(1-135)His6. The sedimentation velocity profiles were fitted to a continuous 
sedimentation distribution. C) Near-UV CD spectrum of Cwf10(1-135)His6. D) Near-UV CD spectrum of 
Cwf10(1-135)His6 in 6 M guanidine-HCl. E) Far-UV CD spectrum of Cwf10(1-135)His6. F) 15N-1H HSQC 
spectra of Cwf10(1-135)His6. G, H) The first 23 amino acids of the Cwf10-NTE are required for efficient splicing. 
RNA was prepared from cwf10+, cwf10-∆NTE, and cwf10 2-23∆ cells grown at 25°C and RT-PCR was done 
using random hexamer primers. A portion of the tbp1 transcript was amplified from the RT-PCR products and 
ratios of mRNA/pre-mRNA were calculated. Quantification represents the average of three biological 
replicates per genotype. Error bars indicate standard error of the mean. 
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FIGURE 2-8
Analysis of recombinant Cwf10(1-135)His6
A) Coomassie stained SDS-PAGE gel of recombinant Cwf10(1-135)His6. Molecular weight 
markers in kilodaltons are shown on left. B) Predicted secondary structure calculated from the 
Far-UV spectrum seen in Fig. 2-7E using the program K2D2 (Perez-Iratxeta and Andrade-
Navarro, 2008). C) 15N-1H HSQC spectrum of Cwf10(1-135)His6 at 50°C. D) 15N-1H HSQC 
spectrum of Cwf10(1-135)His6 in 6 M guanidine-HCl.
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1B). Interestingly, these regions both correspond with predicted regions of order (Figure 
2-7A). Next the protein was analyzed by CD spectrometry using far ultra-violet (UV) 
wavelengths (Figure 2-7E), which can be used to predict secondary structure. Analysis of 
this spectra using the program K2D2 (Perez-Iratxeta and Andrade-Navarro 2008) predicts 
that Cwf10(1-135)His6 in solution is composed of ~10% α-helix and ~31% β-sheet, 
leaving over 50% of the NTE likely disordered (Figure 2-8B).  
To more carefully examine the tertiary structure of the NTE, we 15N labeled 
Cwf10(1-135)His6 and collected a two-dimensional 15N-1H HSQC (Heteronuclear Single-
Quantum Correlation) experiment using nuclear magnetic resonance (NMR) 
spectroscopy. By this analysis we found that the Cwf10-NTE contains 103 well-dispersed 
resonances (out of a total of 141 residues) (Figure 2-7F). When Cwf10(1-135)His6 is 
either heated to 50°C or treated with 6 M guanidine-HCl in order to cause complete 
denaturation of any folded domain(s), the resonance peaks collapse and are no longer 
dispersed (Figure 2-8C and D). Well-dispersed resonances in HSQC spectra result from 
the variable environment of the amines in a folded protein. Thus, the NMR analysis 
confirms both the computational and CD analyses that the Cwf10 NTE contains regions 
of disorder, most likely in the first 60 amino acids (Figure 2-7A), as well as regions that 
adopt a well-ordered secondary structure.  
Interestingly, amino acids 1-23 of the NTE are 70% identical between S. pombe 
and human orthologs (Figure 2-1B), and most of these residues (amino acids 1-17) are 
not predicted to be disordered (Figure 2-7A). To test if this patch of conserved residues is 
required for NTE function, we replaced the chromosomal copy of cwf10+ with cwf10 2-
23Δ to observe whether this smaller truncation would also cause a pre-mRNA splicing 
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defect. RNAs from wild-type, cwf10 2-23Δ, and cwf10-ΔNTE cells were extracted and 
RT-PCR performed (Figure 2-7G). Measures were taken to improve the quantitative 
nature of the PCR (Marone, Mozzetti et al. 2001), including reverse transcribing similar 
amounts of RNA, reducing PCR cycles, and quantifying against an inherent internal 
control (the spliced and unspliced forms are amplified in the same reaction). The ratio of 
mature to premature signal for the tbp1_a intron was almost identical between the two 
truncations (cwf10-ΔNTE 2.1 ± 0.2 vs. cwf10 2-23Δ 2.0 ± 0.3), while the ratio in the wild-
type strain was 9.7 ± 1.5 (Figure 2-7H). This suggests that the conserved, extreme N-
terminus (residues 1-23) is required for NTE function.  
 
The Cwf10 NTE co-purifies with splicing factors 
Spliceosomal binding partners of the NTE have not been determined in any 
organism. We attempted to screen interactions by yeast two-hybrid; however, the assay 
was hindered by the high self-activation of the GAL binding domain when fused to the 
acidic NTE. Therefore, we fused cwf10 2-135 to the N-terminal tandem affinity 
purification (TAP) tag in a pREP41 NTAP vector (Tasto, Carnahan et al. 2001). We 
overexpressed NTAP-NTE in cwf10-ΔNTE cells, performed a two-step TAP purification 
at 150 mM NaCl, and analyzed the eluate using negative stain electron microscopy (EM). 
Although the purification was clearly dilute, we did see particles that were reminiscent of 
negative stain images of the S. pombe U5.U2/U6 complex (Figure 2-9A) (Ohi, Link et al. 
2002, Ohi, Ren et al. 2007), suggesting that the Cwf10 NTE is able to interact with 
spliceosomal complexes on its own. To further characterize the composition of the 
NTAP-NTE purification, we analyzed the protein content of the eluate using 1D LC-
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FIGURE 2-9
Cwf10 NTE can incorporate into spliceosomal complexes and partially rescue 
the splicing defect in cwf10-∆NTE cells
A) Gallery of particles present in NTAP-NTE purifications from cwf10-∆NTE cells as seen by negative stain 
EM. Scale bar is 20 nm. B) NTAP-NTE associates with the U2, U5, and U6 snRNAs. RNA was isolated from 
NTAP-NTE purified from cwf10-∆NTE cells and anti-trimethylguanosine (m3G) purified from wild-type cells. 
Blots were probed with 32P-labeled oligonucleotides complimentary to the S. pombe U1, U2, U4, U5 and U6 
snRNAs. C) Overexpression of the NTEdomain in cwf10-∆NTE cells rescues splicing defects. Total RNA was 
isolated from cells grown at 32°C. RT-PCR was performed with random hexamer primers. Portions of the 
tbp1 and mrps16 transcripts were amplified from the RT-PCR products. Mature (m) and pre-mRNA (p) forms 
are indicated. RT = reverse transcriptase enzyme. D and E) Quantification of mRNA/pre-mRNA ratios for 
three biological replicates per genotype for RT-PCR analysis of tbp1 (D) and mrps16 (E) transcripts. Error 
bars indicate standard error of the mean. F) Overexpression of cwf10 2-23 in cwf10-∆NTE cells does not 
rescue splicing defects. Total RNA was isolated from cells grown at 32°C. RT-PCR was performed with 
random hexamer primers. Portions of the tbp1 and mrps16 transcripts were amplified from the RT-PCR 
products. G and H) Quantification of mRNA/pre-mRNA ratios for three biological replicates per genotype for 
RT-PCR analysis of tbp1 (G) and mrps16 (H) transcripts.
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MS/MS. Peptide counts for spliceosomal proteins found in each LC-MS/MS run are 
included in Table 2-2 to provide a semi-quantitative indication of protein amounts. After 
heat shock proteins (data not shown), the next-highest group of proteins identified in the 
purification comprised pre-mRNA splicing factors that are similar to the S. pombe 
U5.U2/U6 spliceosomal complex (Ohi, Link et al. 2002, Ren, McLean et al. 2011) (Table 
2-2). Highly represented in this group are the Sm proteins, components of the U5 snRNP, 
and components of and related to the hPrp19/Cdc5L complex. Importantly, the EF2-like 
portion of Cwf10 (from the genomic cwf10-ΔNTE allele) was also highly represented, 
confirming the capacity of Cwf10-ΔNTE to incorporate in to higher-order complexes, as 
seen by sucrose gradient sedimentation (Figure 2-5A). The presence of relatively high 
counts of the small, 27kDa U2 snRNP protein Lea1 indicates at least the partial presence 
of the U2 snRNP.   
To examine how closely the NTAP-NTE purification matched endogenous 
U5.U2/U6 complexes, we purified Cdc5-TAP (homolog of Sc Cef1), which associates 
with the Sp U5.U2/U6 complex (Ohi, Link et al. 2002), and performed duplicate 1D MS 
analyses under the same conditions used to analyze NTAP-NTE. The compositions of 
Cdc5-TAP and NTAP-NTE are almost identical (Table 2-2). As one further 
characterization of the NTAP-NTE complex, we analyzed the snRNA content of the 
NTAP-NTE purification from cwf10-ΔNTE cells. As seen in Cdc5-TAP (Ohi, Link et al. 
2002), NTAP-NTE is associated with the U2, U5, and U6 snRNAs (Figure 2-9B). While 
it is possible that a small amount of U1 snRNA is present in the purification (Figure 2-
9B), since no U1 snRNP components were found in the 1D LC-MS/MS analysis (Table 
2-2) this interaction would have to be sub-stoichiometric. Thus, the NTAP-NTE is able to 
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Table 2-2. Splicing proteins co-purifying with NTAP-NTE in a cwf10-∆NTE background and Cdc5-TAP in 
a wild-type background. Two biological replicates were analyzed using one-dimensional (1D) liquid 
chromatography-tandem mass spectrometry (LC-MS/MS) per genotype (I and II). Peptide counts are 
included for each replicate. UNK indicates that an ortholog is unknown or not present. “---“, no peptides 
identified. 
 
  
S. pombe 
 
ORF number 
TAP-NTE Cdc5-TAP  
S. cerevisiae 
 
 
H. sapiens cwf10-∆NTE wild-type 
I II I II 
 
 
 
Core 
snRNP 
Smb1 SPAC26A3.08 4 3 16 6 Smb1 SMB/B’ 
Smd1 SPAC27D7.07c 1 3 12 4 Smd1 SMD1 
Smd2 SPAC2C4.03c 6 3 15 5 Smd2 SMD2 
Smd3 SPBC19C2.14 3 1 15 5 Smd3 SMD3 
Sme1 SPBC11G11.06c 1 1 18 8 Sme1 SME1 
Smf1 SPBC3E7.14 5 3 11 6 Smf1 SMF1 
Smg1 SPBC4B4.05 ---  3 22 9 Smg2 SMG1 
U2 Lea1 SPBC1861.08c 9 3 25 14 Lea1 U2A’ 
Msl1 SPBC8D2.09c 1 ---  10 5 Msl1 U2B” 
Prp10 SPAC27F1.09c --- --- 8 --- Hsh155 SF3B160 
 
 
U5 
Cwf10-ΔNTE SPBC215.12 60 42 --- --- Snu114 U5-116 
Cwf10 SPBC215.12 --- --- 116 54 Snu114 U5-116 
Brr2 SPAC9.03c --- --- 4 --- Brr2 U5-200 
Spp42 SPAC4F8.12c 57 33 221 89 Prp8 U5-220 
Cwf17/Spf38 SPBC1289.11 9 4 53 21 UNK U5-40 
 
 
 
NTC core 
Cdc5 SPAC644.12 34 13 99 50 Cef1 CDC5 
Cwf2 SPAC3A12.11c 13 5 52 20 Cwc2 RBM22 
Cwf7 SPBC28F2.04c 10 6 42 13 Snt309 SPF27 
Cwf15 SPBC337.06c 6 1 23 13 Cwc15 AD002 
Prp5 SPBP22H7.07 14 8 74 26 Prp46 PRL1 
Prp19 SPAC29A4.08c 18 17 93 43 Prp19 PRP19 
 
 
NTC-
associated 
Cwf3 SPBC211.02c 26 9 87 36 Syf1 SYF1 
Cwf4 SPBC31F10.11c 21 11 63 35 Clf1 CRN1 
Cwf5/Ecm2 SPCC550.02c 12 10 64 21 Ecm2/Slt11 RBM22 
Cwf12 SPBC32F12.05c 6 6 25 8 Isy1 ISY1 
Prp45 SPCC188.11 3 3 52 23 Prp45 SKIP 
Prp17 SPBC6B1.10 17 15 51 27 Prp17 hPRP17 
Syf2 SPBC3E7.13c 10 5 16 15 Syf2 SYF2 
 
 
 
 
 
 
Other 
Cwf11 SPBC646.02 36 17 142 55 UNK hCWF11 
Cwf14 SPBC24C6.11 8 4 14 8 Cwc14 G10 
Cwf18 SPCP1E11.07c 6 5 13 9 UNK MGC23918 
Cwf19 SPAC30D11.09 11 3 63 24 UNK hCWF19L2 
Cwf21 SPAC4A8.09c 1 --- 8 1 Cwc21 SRm300 
Cwf22 SPBC13E7.01 2 1 20 6 Cwc22 hCWC22 
Cyp1 SPAC57A10.03 5 1 12 4 UNK PPIL1 
Mug161 SPAC1F3.09 --- --- 8 1 YGR093W CWF19L1 
Prp16 SPBC1711.17 --- --- --- --- Prp16 PRP16 
Prp43 SPBC16H5.10c --- --- 3 3 Prp43 hPRP43 
Prp22 SPAC10F6.02c --- --- 6 --- Prp22 hPRP22 
Saf4 SPBC18H10.10c 3 3 13 4 UNK CCDC130 
Sum3 SPCC1795.11 7 1 1 3 Ded1 DDX3 
unnamed SPAC20H4.09 --- --- 5 3 UNK DHX35 
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bind to a surface(s) of the U5.U2/U6 core without being covalently linked to the EF2-like 
portion of Cwf10 (residues 128-983). Additionally, this suggests that the protein(s) 
and/or RNA(s) that create the binding surface(s) for the Cwf10 NTE are likely present in 
the purified complex of 32 detected spliceosome components. 
Notably, peptides for Brr2, a core U5 snRNP component, were inconsistently 
found in the Cdc5-TAP purifications at both 75 mM and 150 mM salt and were not found 
in either of the Cdc5-TAP or NTAP-NTE purifications from cwf10-∆NTE cells (Table 2-
2). To more closely examine this result, we asked whether NTAP-NTE interacts with 
Brr2 by co-immunoprecipitation. To this end, either NTAP or NTAP-NTE was 
overexpressed in a brr2-3XHA strain. Immunoprecipitations were performed using IgG-
Sepharose beads followed by immunoblotting with anti-HA antibodies to detect Brr2-HA. 
Using this approach, NTAP-NTE pulled down Brr2-HA, while NTAP alone did not 
(Figure 2-10). However, one caveat is that this experiment does not replicate the two-step 
TAP protocol that was used for purifying sample for the mass spectrometry analysis. 
Thus, in aggregate these results show that Brr2 is likely present at only sub-
stoichiometric levels in both NTAP-NTE and Cdc5-TAP purifications, with one 
explanation being that it is not as tightly associated with the U5.U2/U6 complex as other 
U5 snRNP components. 
Because Cwf10-NTE co-purified with spliceosomal components, we next asked 
whether the domain could restore pre-mRNA splicing efficiency in cwf10-∆NTE, i.e. 
function in trans. To test this, we performed semi-quantitative RT-PCR on RNA 
extracted from cwf10-ΔNTE cells over-expressing either NTAP or NTAP-NTE and 
looked at the splicing efficiency of two introns. Analysis of the tbp1_a and mrps16_b 
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FIGURE 2-10
NTAP-NTE co-immunoprecipitates Brr2-HA 
pREP41 NTAP or pREP41 NTAP-NTE were expressed in cwf10-∆NTE brr2-HA cells. NTAP and 
NTAP-NTE were immunoprecipitated with IgG-Sepharose beads and then immunoblotted with 
anti-HA antibodies. Positions of proteins on the immunoblot are labeled.
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introns revealed that overexpression of the NTAP-NTE in the cwf10-ΔNTE background 
improved the mature/pre-mature ratio over the NTAP control by ~25% and 30% 
respectively, returning splicing efficiency close to wild-type levels (Figure 2-9 C-E). 
Although only semi-quantitative, the statistical significance of these data supports a 
model in which the NTE can incorporate into spliceosomal complexes independent of 
any covalent connection with the C-terminal EF2-like portion of Cwf10, partially 
rescuing the splicing deficiency seen in cwf10-∆NTE cells. 
Given the previous result that cwf10 2-127∆ (cwf10-∆NTE) and cwf10 2-23∆ have 
almost identical accumulation of the tbp1_a intron (Figure 2-7G and H), we wondered 
whether overexpressing the first 26 amino acids of the NTE alone would be sufficient to 
restore the pre-mRNA splicing efficiency of cwf10-∆NTE. Therefore, we repeated the 
RT-PCR experiment, using RNA extracted from cwf10-ΔNTE cells over-expressing 
either NTAP or NTAP-Cwf10 2-26. Although Western blotting confirmed the expression 
of the NTAP-Cwf10 2-26 protein (data not shown), the smaller region failed to 
complement deletion of the entire NTE (Figure 2-9 F-H). Thus, the conserved region of 
amino acids 2-23 is necessary for splicing but not sufficient to complement cwf10-ΔNTE 
in trans. 
 
Discussion 
 
Deletion of the NTE and its effects on transcripts 
In this study, we have investigated the function and structural characteristics of 
the Cwf10 NTE. Although this domain is not essential in fission yeast, deletion of the 
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NTE causes a general splicing defect, a change in the sedimentation patterns of in vivo 
spliceosomal complexes, and synthetic lethal and synthetic sick interactions with mutant 
alleles of other pre-mRNA splicing factors.  
Because cwf10-∆NTE cells show robust growth at all temperatures, we were 
surprised to detect a pre-mRNA splicing defect and postulated that the lack of the NTE 
domain may affect the splicing of a specific subset of pre-mRNAs rather than cause a 
global pre-mRNA splicing defect. To test if this was the case, we used deep sequencing 
analysis to comprehensively determine which transcripts are affected by this mutation. 
Interestingly, most introns show a tendency toward reduced splicing efficiency (all points 
to the right of the diagonal in Figure 2-3A), and the reduced splicing is statistically 
significant for about 44% of total introns. It is not surprising, then, that there is no 
obvious type of transcript (i.e. specific splice sites, number of introns, and/or size of 
introns) that is specifically affected. Thus, the splicing defect in cwf10-∆NTE cells 
appears to be global in nature and widespread in scope. This suggests that the NTE is 
important for a general (not transcript-specific) process in the splicing reaction.  
Because functions have not been assigned for any sub-region of the NTE, we 
removed only the first twenty-three amino acids from the NTE and found a similar 
splicing defect between cwf10-∆NTE and cwf10 2-23∆. We speculate that loss of this 
small, highly-conserved, acidic region undermines the NTE’s capacity to bridge 
interactions or support conformational rearrangements in the spliceosome critical for the 
NTE’s function (see “Model” section below). 
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The NTE’s roles in the splicing cycle 
A previous study using Sc Snu114∆N demonstrated a role for the Snu114/Cwf10 
NTE in U4/U6 snRNA unwinding (Bartels, Klatt et al. 2002). However, a study using 
human splicing extracts and antibodies directed against the hU5-116K NTE suggests that 
the NTE may also be involved in the first-to-second step transition (Fabrizio, 
Laggerbauer et al. 1997). This NTE function, uncovered in the human system, is further 
supported by negative genetic interactions (Frazer, Lovell et al. 2009) between Sc 
Snu114∆N and both a substitution at snRNA U6-A59, which inhibits the second step	  of 
splicing (Fabrizio and Abelson 1990), and several alleles of the U5 loop 1, which helps 
position the exons for ligation in the second step (Newman and Norman 1992, O'Keefe 
and Newman 1998).  
Our genetic findings are consistent with a role for the NTE in both spliceosome 
activation and second step catalysis. cwf10-∆NTE interacts with several alleles of genes 
known to be involved in spliceosome activation (Figure 2-6), including spp42-1 (Sc 
PRP8), prp1-4 (Sc PRP6), and cdc5-120 (Sc CEF1). Additionally, the cdc5-120 mutation, 
with which cwf10-∆NTE is synthetically lethal, may play an additional role in second step 
chemistry. First, cdc5-120 is a point mutation in one of the two conserved Myb-repeats 
(Ohi, Feoktistova et al. 1998), a region important for first step to second step modulation 
in ortholog Sc Cef1 (Query and Konarska 2012). Second, cdc5-120 is lethal with S. 
pombe prp17∆ (Ren, McLean et al. 2011), a known second-step splicing factor in S. 
cerevisiae (Jones, Frank et al. 1995). Additionally, a role in the second step is supported 
by the strong negative interaction between cwf10-∆NTE and prp17∆ (Figure 2-6A). The 
fact that the NTE does not immunoprecipitate a pre-activation spliceosome (Table 2-2), 
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but rather a complex similar to U5.U2/U6, could indicate the NTE becomes stably 
“locked” to the spliceosome following activation and is positioned near the catalytic core 
to help modulate the first to second step transition. 
 
Alterations in sizes of snRNA-containing complexes 
 Analysis of snRNAs in cells lacking the NTE shows that loss of this domain 
changes the sedimentation patterns of spliceosomal complexes. Although all the snRNA 
sedimentation patterns show some degree of change in the ∆NTE background (Figure 2-5 
E-N), for both the U1 and U5 snRNAs there is a shift away from higher molecular weight 
fractions into lower molecular mass fractions (<11.3S, Figure 2-5H and L). For the U5 
snRNA, this shift is too high in the gradient (<11.3S, Figure 2-5H) to contain the full 
complement of U5-snRNP specific proteins, as both human and S. cerevisiae U5 snRNPs 
sediment at 15-20S when bound to the U5-specific proteins (Bach, Winkelmann et al. 
1989, Neubauer, Gottschalk et al. 1997). Similar results with the Sc snu114∆N allele led 
the authors to speculate that the NTE is required for U5 snRNP stability (Bartels, Klatt et 
al. 2002), and our results are consistent with that hypothesis. For the U1 snRNA, it is 
unclear whether this lower molecular weight sedimenting fraction represents free U1 
snRNA or the snRNA complexed with at least some of the U1 snRNP proteins. 
Sucrose gradient analysis also revealed that a small fraction of the U2, U5, U6, 
U4 snRNAs, as well as Cwf10, shifted to high molecular mass fractions that are more 
pronounced in cwf10-∆NTE (Figure 2-5B, F, H, J, and N). The presence of this peak at 
fractions 11/12 could suggest that pre-activation spliceosomes are stalled and 
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accumulating. Alternatively, this peak could represent a different multi-snRNP complex 
or aggregates of spliceosome components that are not able to organize properly. 
Although the sedimentation data support a model in which the in vivo cwf10-
∆NTE splicing complexes that are slow to activate or complete catalysis may be 
accumulating or aggregating, other possible fates for stalled spliceosomes include 
degradation by the proteasome and disassembly. The lower steady-state levels of Cdc5 
and Prp1-myc (Figure 2-2I), which sediment mainly as part of large complexes in cwf10-
∆NTE (Figure 2-5C and D and data not shown), could favor the hypothesis that these 
slow-to-splice complexes are degraded. 
 
The NTE’s structure 
Although the NTE was predicted to be intrinsically unstructured in solution 
(Korneta, Magnus et al. 2012), our modeling and biophysical analysis unexpectedly 
showed that approximately half of NTE residues are in a folded environment in solution. 
Because the DISOPRED program (Figure 2-7A) predicted disorder to exist mostly in the 
N-terminus (AA 18-61) of the NTE, and the ordered amino acids to exist at the extreme 
N-terminus (AA 1-17) and the C-terminus (62-120), it is tempting to begin thinking of 
the NTE as three sub-regions with separate characteristics. The extreme N-terminus, 
which is not predicted to be disordered, is required for function, since deleting 23 
conserved residues in the N-terminus fully recapitulates the splicing defect seen when the 
entire NTE is deleted (Figure 2-7G and H). However, this small region cannot 
complement the cwf10 mutant lacking the NTE in trans, suggesting that the C-terminal 
NTE regions are also important. The middle region of the NTE, AA 18-61, which is 
            54
predicted to be disordered, contains many acidic residues. The acidic charge of the NTE 
is likely essential since we were unable to integrate a cwf10 mutant that had all 
negatively-charged residues in AA 1-61 replaced with alanine residues (data not shown). 
The proposed third region of the NTE, amino acids 62-120, is predicted to be structured 
and links the N-terminal NTE regions to the “EF2-like” portion of the protein. Further 
studies are needed to delineate the boundaries of order and disorder within the NTE, as 
well as to determine how these regions may interact with each other. 
The unstructured region(s) of the NTE may become folded in the context of the 
dynamic spliceosome when it comes into contact with a binding partner(s). This idea has 
precedent in the pre-mRNA splicing machinery. A 70 amino acid intrinsically disordered 
region of NTC-associated protein hSKIP undergoes a disordered-to-ordered transition 
upon binding to cyclophilin PPIL1 (Wang, Zhang et al. 2010). Similarly, a 31 amino acid, 
predominantly random coil region of human U4/U6-60K adopts structure when bound to 
U4/U6-20K (another cyclophilin) (Reidt, Wahl et al. 2003). However, the disordered 
regions of hSKIP or U4/U6-60K do not share the same high acidic content of the 
proposed disordered middle region of the NTE, AA 18-61. The determination of binding 
partners for the NTE will pave the way for experiments to examine whether order-to-
disorder transitions occur within this domain.  
 
Potential binding environment in the spliceosome 
When overexpressing NTAP-NTE (Cwf10 residues 2-135) in cwf10-∆NTE cells, 
we found this fragment has the capacity to incorporate into a spliceosomal complex that 
is similar in composition to the S. pombe U5.U2/U6 complex. From this observation, we 
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conclude that the Cwf10-NTE recognizes and interacts with other spliceosomal 
components independently of its polypeptide linkage to the main Cwf10 “EF2-like” 
portion. What does the NTE bind to in the context of the late-stage spliceosome? Likely, 
the binding site does not involve Brr2, because it is not present at stoichiometric amounts 
in the purification (Table 2-2), although other U5-specific proteins Spp42 (Sc Prp8), 
Spf38 (human U5-40), and the EF2-like portion of Cwf10 are highly represented. 
Therefore, the binding partner(s) is likely one of the above U5-specific proteins, the U5 
Sm core, U2 snRNP protein Lea1, or one or more of the NTC and NTC-related proteins. 
Additionally, the specific genetic interactions of Sc snu114∆N with snRNA alleles 
(Frazer, Lovell et al. 2009) may also support an orientation of the NTE near U5 loop 1 
and U6.  
Importantly, NTE binding partners may change as protein-protein, protein-RNA, 
and RNA-RNA rearrangements occur during the splicing reaction. The combination of 
structured and unstructured regions within the NTE may allow the domain to bridge 
transient conformational states adopted by the spliceosome as splicing occurs. However, 
regardless of exact mechanism, the presence of the Cwf10 NTE in trans is sufficient to 
partially rescue the splicing defect seen in cwf10-∆NTE cells. There are other 
spliceosome proteins that can function when their domains are expressed separately, 
highlighting the multiple interactions between spliceosome components. Examples 
include the large, 280kDa Sc Prp8 (Boon, Norman et al. 2006) and first-step factor Sc 
Yju2 (Chiang and Cheng 2013).  
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Model of Cwf10 NTE interactions in the spliceosome 
Based on our data and the work of others outlined above, we propose a model of 
NTE function that includes (a) stabilization of the U5 snRNP structure and (b) facilitation 
of specific conformations among U5 snRNP components or between the U5 snRNP and 
other spliceosome proteins/RNAs. The NTE is capable of independently incorporating 
into the spliceosome and likely makes contact with more than one splicing component 
through its predicted structured and unstructured regions. Although we were not able to 
determine specific binding partners for the Cwf10 NTE, these partners must be in the 
vicinity of the EF2-like portion of Cwf10. It is tempting to speculate the these contacts 
promote cohesion within the U5 snRNP, and may transmit a signal or form a stabilizing 
bridge, first within the context of the pre-activation Complex B, then near the catalytic 
center of Complex C. 
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CHAPTER III 
 
RANDOM MUTAGENESIS OF SPLICEOSOMAL GTPase CWF10 
 
Introduction 
While great advances have been made in the past decades toward deciphering the 
pre-mRNA splicing process, much remains to be learned, particularly about the specific 
interactions that exist among the spliceosome’s numerous polypeptides and snRNAs. To 
this end, structural studies have determined atomic-level structures of individual domains 
of pre-mRNA splicing factors using x-ray crystallography and defined the general shapes 
of spliceosome intermediates through single-particle electron microscopy (EM) 
(reviewed in Zhang, Li et al. 2013). Indeed, one such intermediate, the U5.U2/U6 
complex from S. pombe, was characterized using EM in our lab (Ohi, Ren et al. 2007). 
However, the resolution achieved in these EM density maps needs to be improved from 
the current  ~30 Å to better than 10 Å in order to begin observing specific interactions 
among components.  
In this study, we investigate whether more homogenous spliceosome populations 
can be purified from S. pombe, with the aim of achieving higher-resolution EM models of 
these spliceosomes. Our approach was to purify complexes from cells that have a block 
in splicing progression. Heat- and cold-sensitive yeast harboring mutations in 
spliceosome components often block in vitro splicing reactions at a particular step, and 
recently such mutants have been used to biochemically and structurally analyze 
spliceosome intermediates (Warkocki, Odenwälder et al. 2009, Lardelli, Thompson et al. 
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2010). Toward this end, we used a random mutagenesis strategy to produce multiple 
cwf10 mutant strains. Cwf10 is the EF2-like GTPase component of the U5 snRNP that, as 
discussed in detail in Chapter I, occupies a position near the splicing catalytic site and has 
the capacity to favor or inhibit certain structural transitions through its nucleotide-binding 
status. We herein characterize the cellular and splicing phenotypes of the mutant strains 
and biochemically analyze changes in the spliceosome complexes present in cell lysates. 
These data suggest that our cwf10 mutant strains contain destabilized multi-snRNP 
complexes, as marked by the pre-mRNA splicing factors Cdc5 and Prp1, and thus are not 
useful tools for isolating complexes for EM analysis. 
 
Results 
 
Nine ts alleles are isolated by random mutagenesis 
In order to isolate cwf10 ts mutants, we employed a random mutagenesis strategy 
of cwf10+::kanMX6 PCR fragments (Figure 3-1A). The fragments were amplified using 
error-prone PCR and transformed into yeast carrying wild-type cwf10+. Integrants were 
isolated from YE G418 plates at 25°C, and ts colonies were identified by their failure to 
grow on YE at 36°C. All together, nine distinct ts alleles were isolated (cwf10-2 through 
cwf10-10). Each mutated ORF contained on average 6.0 base pair changes, which caused 
4.1 amino acid changes. Three different mutagenesis conditions were used to produce 
these nine alleles, and we wondered whether the mutation rate was responsive to the 
error-prone PCR conditions used. Three (3) mutants were isolated by using 15 cycles of 
error-prone PCR of the entire gene (3,093 bp; blue arrows Figure 3-1A), and these 
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cwf10 ts alleles generated by random mutagenesis contain multiple mutations
A) A kanMX6 cassette (dashed lines and box) conferring G418 resistance was introduced 3’ of 
the cwf10 gene at its endogenous locus. Following integration, the cwf10-kanMX6 sequence 
was amplified by PCR with primers 500 bases upstream and downstream (blue arrows). This PCR 
amplicon served as a template to mutagenize the full length (blue arrows) or C-terminal (red 
arrows) cwf10 ORF at random sites using Taq polymerase (see Methods). Mutagenized PCR was 
transformed in to yeast with an unmodified cwf10+ locus, and integrants were selected on G418 
media at 25°C. After replica plating to rich media at 36°C, temperature sensitive (ts) strains were 
isolated. B) Table grouping nucleotide substitutions found in alleles cwf10-2 through -10 by their
frequency of occurrance. C) Table listing the exact amino acid substitutions found in each cwf10
allele grouped by domain. D) Linear representation of the domains of Cwf10, as defined by 
homology to EF2. Mutations are represented as vertical lines underneath the position of the 
amino acid, with the Cwf10 allele carrying the mutation (-1 through -10) encircled below. 
Conservative amino acid substitutions are indicated in peach, while non-conservative substitutions 
are indicated in black. The G’ subdomain is AA 328-435. “N” indicates the N-terminal domain. The 
two mutagenesis target fragments - full length and C-terminal - are depicted above the domains.
       
Name NTE Domain I Domain II Domain III Domain IVa/b Domain V 
Cwf10-1a   C323Y         
Cwf10-2  
V161I, K172R, 
S362L  M596K N711I S879T 
Cwf10-3   L266P E525D   D752V   
Cwf10-4         G716E, D941G 
E848K, 
D854N, 
G878V 
Cwf10-5     
T682A, R726G, 
L804Q, D923A, 
V980E  
Cwf10-6         E795V 
C894G, 
V902E 
Cwf10-7       
H640L, 
E665G S689T, L983S G895E 
Cwf10-8     G517C I593T C676R, M700V   
Cwf10-9         E703V, G818D S893Y 
Cwf10-10 E116D M230K       Y882F !
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mutants had an average of 2.3 mutated bases/kb. Two (2) mutants were isolated from 8 
cycles of PCR covering the entire gene, with an average of 1.8 mutated bases/kb. The 
remaining four (4) mutants were isolated from transformation of 15 cycles of the 3’ end 
of the gene (1,100 bp; red arrows, Figure 3-1A), and these mutants had an average of 5.0 
mutated bases/kb. These results indicate a mutation rate dependent on the PCR conditions 
and a trend toward more mutations with more error-prone PCR cycles. The specific base 
pair changes were also analyzed to determine the biases present in this protocol. 
Specifically, five of the sixteen possible base pair changes were over-represented, while 
seven of the sixteen occurred infrequently (Figure 3-1B). While these data may be 
influenced by the requirement that the set of mutations resulted in a viable allele in order 
to have been sequenced, the information may still be useful when applying this method to 
other genes to determine error-prone PCR parameters and predict base changes. 
The amino acid substitutions associated with each cwf10 ORF are listed in Figure 
3-1C.  We created a visual representation of these substitutions indicating (a) whether the 
substitution was conservative or non-conservative and (b) in which domain the mutation 
occurred (Figure 3-1D). The mutated amino acids are spread throughout all domains of 
the protein, although there is a clear preference for accumulation of mutations toward the 
C-terminus (domains IV and V). This is likely due in part to the four mutants that were 
generated by mutating only the C-terminus (cwf10-4 through -7; red line, Figure 3-1D). A 
previously described ts point mutant, cwf10-1 (Bayne, Portoso et al. 2008), is also 
diagrammed in Figures 3-1C and 3-1D and is phenotypically analyzed in following 
sections. 
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cwf10 mutants display defects in growth, splicing, and silencing  
of heterochromatin transcription 
As expected from alleles harboring different mutations, the mutants displayed a 
range of growth rates on solid media at 18°C and 32°C, with all displaying cell death at 
36°C (Figure 3-2A). The ts phenotype was further investigated in a subset of alleles by 
quantifying cell growth in liquid cultures. All mutants displayed negligible growth 
compared with wild-type following placement in 36°C YE media (Figure 3-2B). We 
wanted to confirm that the ts phenotypes were truly caused by mutations in the cwf10 
ORFs. To investigate this, we expressed a high-copy vector containing the cwf10 ORF in 
the context of  ~500 bp native upstream and downstream chromosomal sequence, and 
expressed the vector in several mutants, including cwf10-1 and three mutants isolated 
from the random mutagenesis screen. The wild-type pIRT2 cwf10+ plasmid rescued 
growth of every cwf10 mutant, but not of a prp4 mutant (Figure 3-2C), indicating that 
these mutations are recessive and can be complemented by the cwf10+ chromosomal 
sequence. S. pombe ts mutants can arrest in a variety of cell shapes and sizes, which often 
correlate with an interpretation of cell cycle defects (Fantes 1977, Potashkin, Kim et al. 
1998). In every case examined, the cwf10 ts mutants arrested as long cells, rarely with 
more than one septum, indicating a block in mitotic progression and subsequent cell 
septation (Figure 3-2D). 
We next wanted to determine whether these cells had splicing defects. The 
presence of an increased splicing defect upon shift to 36°C would support the idea that 
cell death in these mutants is caused by a defect in the splicing machinery. RNA was 
extracted from each mutant grown at 25°C and 36°C, and semi-quantative reverse 
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FIGURE 3-2
cwf10 ts mutants exhibit cell growth and morphology defects
A) The strains indicated were serially diluted and spotted on YE at the indicated temperatures to 
assay temperature-specific growth defects. B) Cells of the indicated strains were grown at 25°C 
and filtered in to 36°C rich media at an approximate concentration of 1.5x106 cells/mL. Cells 
were counted every hour. C) The strains indicated were transformed with either pIRT2 or pIRT2
containing the cwf10 genomic sequence. Transformants were struck to MAU plates at the
indicated temperatures. D)  The indicated strains were grown in YE media at the indicated
temperatures and imaged with brightfield microscopy. 
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transcriptase-PCR (RT-PCR) analysis of the first tbp1 intron was performed (Figure 3-
3A). ts alleles displayed splicing defects at 25°C, and the defect was exacerbated by the 
36°C temperature shift. Interestingly, however, unlike in the temperature-shifted prp2-1 
and prp4-73 mutants, for the cwf10 mutants the mature (spliced) band remains strong at 
36°C (Figure 3-3A). Other introns besides tbp1_a were not tested.  
The connection between the splicing machinery and RNAi processes has been 
appreciated only recently (Dumesic, Natarajan et al. 2013, Tabach, Billi et al. 2013), and 
we wanted to investigate this connection using our cwf10 mutants. Cwf10 has previously 
been shown to co-isolate with RNAi processing factors, and the cwf10-1 allele alleviates 
silencing of genes located in the centromeric heterochromatin (Bayne, Portoso et al. 
2008), which, in fission yeast, is maintained in part by RNAi (Buhler and Moazed 2007, 
Grewal and Jia 2007). We asked if our cwf10 alleles also had gene silencing defects, 
using RT-PCR amplification of the cen-dg heterochromatic transcripts, which are 
normally silenced. Indeed, at the permissive temperature of 25°C, all cwf10 alleles 
displayed accumulation of cen-dg RNAs in abundance similar to deletion of the known 
chromatin silencing factor swi6 (Figure 3-3B). This defect is not observed in splicing 
factor mutants prp2-1 and prp4-73. 
 
cwf10 mutations cause changes to spliceosomal complexes 
Because our ultimate goal was to use these ts alleles to isolate a homogenous 
splicing complex, we began biochemically probing spliceosomes in these mutants. 
Alleles cwf10-1, -8, -9, and -10 were chosen to investigate further because their non-
conservative amino acid substitutions lie in different domains of Cwf10 (Figures 3-1C 
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FIGURE 3-3
cwf10 ts mutants exhibit splicing defects and transcription from centromeric
heterochromatin
A) Total RNA was isolated from cells grown at 25°C (permissive temperature) or grown at 25°C 
and shifted to 36°C for six hours (restrictive temperature). RT-PCR was performed with random 
hexamer primers. From the RT-PCR reactions, portions of the tbp1 (containing introns) and act1 
(intronless) transcripts were amplified by PCR. Mature (m) and pre-mRNA (p) forms are indicated. 
No bands were detected in any RT-PCR samples in which the reverse transcriptase enzyme was 
omitted (-RT). B) Accumulation of centromeric transcripts in cwf10 mutants. Total RNA was 
isolated from cells grown at 25°C. RT-PCR was performed with an oligo(dT)12–18 primer, and 
tbp1 (containing introns), cen-dg (centromeric), or act1 (intronless) transcripts were amplified from 
RT-PCR products. Mature (m) and pre-mRNA (p) forms are indicated. No bands were detected in 
any RT-PCR samples in which the reverse transcriptase enzyme was omitted (-RT).
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and 3-1D). Cwf10-1 contains a substitution in domain I, Cwf10-8 in domains III and IVa, 
Cwf10-9 in domains IVa and V, and Cwf10-10 in domain V. Because mutations in 
different S. cerevisiae Snu114 domains have different biochemical effects on 
spliceosomes (Brenner and Guthrie 2006), we reasoned that these different alleles would 
possibly impair splicing progression uniquely.  
We first investigated the density gradient sedimentation of two marker 
spliceosome proteins, Prp1 and Cdc5. Prp1 associates with a group of proteins that 
resembles a pre-activation spliceosome (Carnahan, Feoktistova et al. 2005), while Cdc5 
immunoprecipitates exclusively U5, U2, and U6 snRNAs and proteins reminiscent of a 
post-activation spliceosome (Ohi, Link et al. 2002). Although we have never observed 
the sedimentation pattern of Cdc5 to change in any spliceosome mutant background ((Ohi, 
Link et al. 2002) and data not shown), Prp1-myc readily redistributes to <19S in a two 
hour prp2-1 arrest (data not shown). The mutant cwf10 strains were arrested for six hours 
at 36°C before loading the lysates on density gradients. We observed that the 
sedimentation pattern of Cdc5 was relatively unchanged in the mutants (Figure 3-4A, 
right blots). Prp1-myc did not shift to the top of the gradient as in prp2-1; however, the 
sedimentation pattern >37S appeared to be altered among the tested alleles (Figure 3-4A, 
left blots). These differences were difficult to quantify because the Western blot signal 
from Prp1-myc in the mutants was very low. We used lysates to calculate the levels of 
Prp1-myc and Cdc5 against levels of housekeeping protein Asp1, using near-infrared 
Western blotting (Figure 3-4B). Interestingly, the marker proteins were reduced 47-91% 
in each cwf10 mutant shifted to 36°C for 6 hours. The reduced protein level of Cdc5 and 
its similar sedimentation profile in all mutant strains indicated that the remaining Cdc5 
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Spliceosome complex marker proteins Prp1 and Cdc5 become less abundant in cwf10 ts arrests
A) Lysates from strains shifted to 36ºC for six hours were run over 10-30% sucrose gradients. Every other 
fraction was blotted for the indicated proteins. 19S and 37S were determined by the sedimentation of 
thyroglobulin and Cdc5, respectively. B) Lysates from strains shifted to 36ºC for six hours were blotted for 
the indicated proteins and quantified against each lysate’s amount of housekeeping protein Asp1. The 
graph represents a single biological/technical replicate.
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protein remained bound to its normal 37S complex. Likewise, the reduced protein level 
of Prp1-myc and possible shifts in its sedimentation indicated Prp1-myc-containing 
complexes are reduced in number, and these complexes may be altered in composition or 
conformation. 
To further clarify the behavior of multi-snRNP complexes in the cwf10 mutants, 
we ran lysates over density gradients and isolated the RNA from each fraction. Blotting 
for the U5 snRNA, which participates in both pre- and post-activation spliceosomes, we 
observed that U5 no longer sediments mainly in a ~40S peak (Figure 3-5A, fraction 9, 
and quantified in Figure 3-5D), but rather sediments below 11.3S in the cwf10-1 and -9 
alleles. The sedimentation of U5 in the prp2-1 arrest clearly shows the presence of a 
<11.3S peak (fraction 2) and a ~19S peak (fraction 5). The 19S peak is large enough to 
contain the U5-specific proteins, including Cwf10, while the <11.3S peak likely contains 
only the U5 snRNA with or without the Sm ring (Bach, Winkelmann et al. 1989, 
Neubauer, Gottschalk et al. 1997). This result indicates that these cwf10 ts mutants cause 
(a) U5 snRNA to dissociate from high molecular weight complexes and (b) Cwf10 and 
other U5-specific proteins to dissociate from the U5 snRNA. Additional blotting for the 
U2 and U6 snRNAs (Figures 3-5B and 3-5C) and quantification in Figures 3-5E and 3-5F 
shows the redistribution of U2 from the peak at fraction 9 to two separate patterns in 
cwf10-1 and cwf10-9, as well as the almost complete removal of U6 from high molecular 
weight fractions in these mutants. This, along with the reduced protein levels of Cdc5 
(Figure 3-4B) suggests that U2, U5, and U6 no longer associate as a multi-snRNP 
complex at high levels and that splicing defects in these strains are likely due, at least in 
part, to lack of assembled splicing complexes. 
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 cwf10 mutations cause reduced levels of Cwf10 protein 
Finally, we asked what happens to the stability of the mutant Cwf10 proteins. 
Using polyclonal Cwf10 antiserum developed for this project (characterized in Figure 2-
2D), the levels of Cwf10 in all the mutants was determined to be significantly lower than 
wild-type, even at the permissive temperature of 25°C (Figure 3-6). Although it is not 
clear whether the proteins are inherently unstable, or if they are degraded in response to 
altered interactions with the spliceosome, these data led us to consider the possibility that 
the splicing phenotypes of the cwf10 ts mutants were all attributable to destabilization of 
the Cwf10 protein structure, rather than to alterations in specific domains of the protein. 
Even if there were unique domain-specific effects being exerted on spliceosomes, the low 
levels of the Cdc5 and Prp1 marker proteins indicated that it would be difficult to isolate 
large quantities of these complexes to analyze by single-particle EM. 
 
Discussion 
In this study, random mutagenesis by PCR was used to generate ts alleles of 
cwf10. We generated a panel of nine mutants with different sets of mutations; however, it 
is unclear whether the mutations generally destabilize the protein or whether they inhibit 
splicing by mechanisms unique to each mutant. We have used this method to generate ts 
strains with other targeted spliceosome mutations, including cwf5 S166P (Livesay and 
Ohi, unpublished observation) and multiple cdc28 mutants (Takizawa and Ohi, 
unpublished observations), although the same question remains of how the mutations 
exert the splicing defect. The mutagenesis method is not suitable for every gene, as 
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demonstrated by our multiple unsuccessful attempts to generate a prp19 ts strain. Another 
caveat of this approach is that the mutants must have properties that allow them to be 
screened by replica plating, such as sensitivity to temperature or a drug. It is notable that 
all of the ts mutants we isolated (cwf10-2 through -10) contained multiple mutations. 
Since it has been demonstrated that a single mutation ts cwf10 strain can be generated 
(cwf10-1, recovered from EMS-treated cells) (Ekwall, Cranston et al. 1999), we 
hypothesize that parameters of the mutagenesis PCR reaction could be modified to favor 
recovery of single-mutation alleles. 
cen-dg transcript accumulation in cwf10 mutant cells (Figure 3-3B), and previous 
work on cwf10’s role in RNAi processing (Bayne, Portoso et al. 2008) beg the question 
of how Cwf10 protein is required for these processes. The current understanding of 
spliceosome interaction with RNAi machinery places the two processes in competition 
(Dumesic, Natarajan et al. 2013). That is, weak splicing substrates, which do not undergo 
the kinetic mechanisms of forward splicing as quickly as strong substrates, are more 
likely to be processed by the RNAi machinery. When the spliceosome is stalled on the 
substrate, the RNAi machinery has opportunity to access and process the transcript. It is 
not immediately apparent, then, how a splicing mutant that, presumably, would cause 
additional stalling in splicing, would cause inefficient RNAi processing. One idea is that 
Cwf10 is involved in the association of the RNAi machinery with the spliceosome. If 
Cwf10 is not able to recruit the RNAi machinery efficiently, then the transcript will not 
be processed by the RNAi machinery, even if splicing is stalled. Another idea is that the 
spliceosome does not actually form correctly on the transcript, thus not recruiting the 
RNAi machinery. We see that the U5 snRNP is largely disassembled in the mutant 
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(Figure 3-5A), possibly indicating that Complex B cannot form from Complex A already 
assembled on the transcript, because U5 snRNP and thus the U5.U4/U6 tri-snRNP are not 
available to bind. 
It is intriguing to note how the snRNAs have dramatically altered sedimentation 
patterns in the cwf10 mutant arrests while the spliceosome proteins Cdc5 and Prp1 have 
relatively unaltered sedimentation patterns (Figure 3-4A). Upon temperature shift of the 
cwf10 mutants, several of the snRNA signals shift mainly to low molecular weight 
fractions (Figure 3-5 D-F), while Cdc5 and Prp1-myc remain mostly visible in higher 
molecular weight fractions. One explanation is that Cdc5 and Prp1 are somehow 
degraded when their complexes are disassembled, while the snRNAs (probably in 
complex with the Sm/Lsm proteins) remain stable. We also considered that transcripts of 
cdc5 and prp1 are not spliced properly, and thus less protein is produced; however, the 
prp1 transcript contains no introns. It is possible that Cdc5 and Prp1 are vulnerable to 
degradation as unfolded proteins when they are not in complexes; another intriguing 
possibility is that a specific component(s) of a stalled spliceosome is targeted by 
ubiquitination for proteasomal degradation. While ubiquitination is a known process in 
the splice cycle (Bellare, Small et al. 2008, Song, Werner et al. 2010), no targeted 
proteasomal degradation process has been described. 
Based on the low levels of Prp1-myc and Cdc5 protein in arrested cwf10 mutant 
cells, we propose that these mutants are not good choices for isolating large quantities of 
homogenous multi-snRNP complexes for structural analysis. There are some other 
possible ways to use cwf10 for structural analysis discussed below. One is the isolation of 
cwf10 alleles that are not temperature sensitive. cwf10-ΔNTE cells, for example, grow 
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well at a range of temperatures and have high steady-state protein levels of Cwf10 ΔNTE 
(see Chapter II). Although that mutant’s levels of Prp1-myc and Cdc5 are reduced, 
similar mutations may exist that slow splice cycle progression through a certain transition, 
yet maintain levels of that complex. Another possibility is overexpression of cwf10 
alleles. Preliminary results with overexpressed pREP3X cwf10 E842I (OHI plasmid 863) 
indicate that the allele causes cells to die, even though chromosomal cwf10+ is also 
expressed. This dominant negative phenotype could indicate that Cwf10 E842I sequesters 
other spliceosome components in a stalled complex, reducing their availability to bind 
with wild-type Cwf10. It would be interesting to TAP-tag this overexpressed allele and 
examine co-purifying complexes for protein composition, snRNA composition, and types 
of splicing intermediates. 
 
 
 
 
 
 
 
 
 
 
 
 
            74
CHAPTER IV 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
Snu114/Cwf10 plays several roles in pre-mRNA splicing as a U5 snRNP 
component and the sole spliceosomal GTPase. In this work, I have examined 
Schizosaccharomyces pombe Cwf10 through genetic, biochemical, and biophysical 
means to better understand its functions and mechanisms of action. 
 
Chapter highlights 
In chapter II, I explored the functional and structural characteristics of the N-
terminal extension (NTE) domain of Cwf10. Deletion of the NTE led to a global splicing 
defect, suggesting the NTE is required for a general, not transcript-specific, process in the 
splicing reaction. The Cwf10 ∆NTE protein was stably expressed and retained the 
capacity to associate with high molecular weight complexes; however, there was an 
increased presence of Cwf10 ∆NTE over wild-type Cwf10 in some particularly large 
complexes of unknown composition. The NTE deletion also caused an increase in U5 and 
U1 snRNAs found in low molecular weight fractions, probably mono-snRNPs. Our 
genetic findings were consistent with roles for the NTE in spliceosome activation and 
second-step catalysis. The biophysical characteristics of recombinant NTE led us to 
propose a model by which, in solution, the NTE contains a short, structured segment 
followed by two larger segments, the first disordered and the second ordered. The NTE, 
expressed as a single domain, co-immunoprecipitated U5.U2/U6 spliceosome almost 
            75
exclusively, suggesting the domain is stably bound when associating with this 
spliceosome stage. The overexpressed NTE complemented the splicing defect of cwf10-
∆NTE, suggesting that the NTE can efficiently localize to the spliceosome and function 
even when the domain is not fused to the rest of Cwf10. We conclude that the NTE is 
important for multiple phases of the splice cycle and may be composed of structurally-
distinct regions with high affinity for distinct binding partners, causing the NTE to stably 
incorporate into the catalytic-stage spliceosome. 
In chapter III, I applied a PCR-based mutagenesis strategy to create genomic 
mutants of cwf10. Nine ts alleles were recovered, all with unique mutations. The 
mutations caused amino acid changes covering every domain of the protein. The mutants 
(cwf10-2 through cwf10-10) generally displayed splicing defects at both the restrictive 
and permissive temperatures, and they displayed heterochromatin-silencing defects at the 
permissive temperature. The mutants caused levels of multi-snRNP protein markers Cdc5 
and Prp1 to decrease, and snRNA sedimentation patterns in the mutants shifted, 
providing clues to the mechanism of the ts alleles’ effects on splicing. Finally, even at the 
permissive temperature, the mutant Cwf10 proteins appeared unstable, with lower steady-
state levels as determined by Western blot. It is likely that the mutated forms of Cwf10 
are unstable and do not support efficient function. Multi-snRNP complexes, marked by 
Cdc5 and Prp1, became much less abundant in the mutants, possibly because 
spliceosomes formed inefficiently and the individual components were vulnerable to 
degradation. We conclude that these cwf10 ts mutants are unlikely to be useful for 
purifying multi-snRNP structures for analysis by single-particle EM. 
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Taken together, these studies highlight the functions of Cwf10, advancing the 
field’s understanding of Cwf10 NTE structure, global importance for splicing, and 
binding partners, and providing a clearer understanding of genetic means in S. pombe for 
preparing homogenous spliceosome purifications. This work paves the way for several 
paths of future investigation. 
 
Addressing Cwf10’s position within the catalytic core 
Snu114/Cwf10 has several connections to spliceosome catalysis. As discussed in 
Chapter I, Cwf10 has genetic and biochemical interactions with Prp8, which is near, and 
may form part of, the active site. Additionally, human Cwf10 and Prp8, under chaotropic 
salt conditions that disrupt most U5 snRNP interactions, remain stably bound, suggesting 
that the shared interfaces are extensive (Achsel, Ahrens et al. 1998). This work and the 
work of others (Fabrizio, Laggerbauer et al. 1997, Liu, Laggerbauer et al. 1997, Frazer, 
Lovell et al. 2009) supports a role for Cwf10 in the second step of splicing, indicating the 
protein must be in a position to affect the catalytic core, directly or indirectly. While 
yeast two-hybrid assays have been helpful in determining interactions between specific 
regions of Cwf10 and Prp8 (for example, Boon, Norman et al. 2006 and Hegele, 
Kamburov et al. 2012), there are currently no co-crystal structures of Cwf10/Prp8 
interfaces, as there are for Brr2/Prp8 regions (Mozaffari-Jovin, Wandersleben et al. 2013). 
Thus the three-dimensional orientation of Cwf10 in relation to Prp8 is unclear. An 
extensive genetic analysis of S. cerevisiae Cwf10 alleles with snRNA alleles (Frazer, 
Lovell et al. 2009) was interpreted to support the orientation of Cwf10 domain I near 
exon 1 prior to the first catalytic step. Human Cwf10 can be specifically crosslinked to 
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exogenous hairpins inserted between the branch point and 3’ SS that block the second 
step (Liu, Laggerbauer et al. 1997). These data are consistent with Cwf10 being located 
near the substrate and having an active role in locating the 3’ SS before second step 
catalysis. 
While the relative positions of the Cwf10 domains are expected to be similar to 
those of homolog EF2, the NTE is not present in EF2. Thus, the relative orientation of the 
NTE to the other Cwf10 domains and/or other binding partners is unknown. However, 
the NTE may be oriented toward the 3’ SS of the pre-mRNA, as two studies (Fabrizio, 
Laggerbauer et al. 1997, Frazer, Lovell et al. 2009) as well as my genetic data (Figure 2-
6) have implicated the NTE domain in facilitating the second step. 
Crystallization of the entire catalytic core of the spliceosome would provide 
amazing structural insight about, among many things, the orientation of Cwf10. 
Difficulties lie, however, in purifying sufficient quantities of the core and isolating a 
homogenous core complex from assembled spliceosomes. An alternative approach, 
building the core from recombinant components, is perhaps more prohibitive, as the 
components could not organize themselves into a functional active site without 
undergoing spliceosome assembly. Additional yeast two-hybrid, co-IP, and RNA binding 
assays of Cwf10 with candidate proteins and RNAs in the spliceosome may provide tools 
to better understand Cwf10’s positioning in the spliceosome during catalysis. 
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Understanding mechanisms of NTE’s functions in U5 snRNP  
stability and spliceosome activation 
Apart from the NTE’s positioning prior to second step catalysis, the NTE may 
contact different binding partners and be oriented differently in the U5 snRNP and the 
U5.U4/U6 tri-snRNPs. This is suggested by the NTE’s additional functions in U5 snRNP 
stability (Bartels, Klatt et al. 2002 and Figure 2-5G and H) and in activation of the 
spliceosome (transition from Complex B to Complex B’) (Bartels, Klatt et al. 2002). 
The NTE could function actively in U5 snRNP stability, playing a role in the 
assembly or recycling of the U5 snRNP, or it could function passively, preserving 
important interactions that are disrupted by the NTE’s absence. As no enzymatic activity 
has been reported for the NTE, an active role is less likely. de novo U5 snRNP formation 
involves the binding of Prp8 and Cwf10 to the cytoplasmic protein Aar2 (Boon, Grainger 
et al. 2007, Weber, Cristao et al. 2011). The cwf10-ΔNTE aar2Δ double mutant grew 
fairly well at all temperatures (Figure 2-6A), indicating that the NTE’s function in U5 
snRNP stability may occur after the initial assembly with Aar2. Structural data of the 
NTE’s positioning in the U5 snRNP will be essential in understanding how the NTE 
stabilizes the snRNP. 
The NTE’s function in spliceosome activation is not defined specifically enough 
to hypothesize a mechanism of action. It could facilitate an early step, such as U4/U6 
unwinding, or a later step, such as the helicase Prp2-mediated remodeling of the Complex 
Bact to Complex B’ (Complex Bact is a recently described intermediate between Complex 
B and Complex B’) (Warkocki, Odenwälder et al. 2009). Our genetic analysis of the 
cwf10-ΔNTE allele provides some clues as to the timeframe. cwf10-ΔNTE is synthetically 
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sick with prp4-73, an allele of the splicing kinase. Prp4 kinase has been shown to 
phosphorylate Prp1 (homolog of human U5-102) in S. pombe and human systems and to 
phosphorylate PRP31 in the human system (Schwelnus, Richert et al. 2001, Schneider, 
Hsiao et al. 2010). Prp1 and PRP31 are both components of the U5.U4/U6 tri-snRNP and 
leave the spliceosome prior to Complex Bact formation (Fabrizio, Dannenberg et al. 2009). 
The cwf10-ΔNTE prp4-73 interaction suggests the NTE may act in an early stage of 
activation. Additional evidence for this comes from the synthetic lethality of cwf10-ΔNTE 
with prp1-4. Prp1 is thought to be the major “bridge” connecting the U5 snRNP to the 
U4/U6 di-snRNP (Makarov, Makarova et al. 2000, Bottner, Schmidt et al. 2005, Liu, 
Rauhut et al. 2006). The genetic interaction indicates the NTE may be required for a 
function of Prp1 either in tri-snRNP formation, tri-snRNP incorporation in Complex B, or 
conversion of Complex B to Complex Bact. Finally, cdc28-P8, an allele of helicase Prp2, 
displayed no synthetic phenotype with cwf10-ΔNTE. Prp2 acts late in activation, 
facilitating the Complex Bact to Complex B’ transition (Warkocki, Odenwälder et al. 2009, 
Lardelli, Thompson et al. 2010, Ohrt, Prior et al. 2012). These data further support a role 
for the NTE in an earlier step of spliceosome activation. The S. cerevisiae Snu114ΔN 
mutant did not interact with any U4 mutations that would stabilize U4/U6 basepairing, 
suggesting that the NTE does not facilitate the early activation step of U4/U6 unwinding 
(Frazer, Lovell et al. 2009). These data together may implicate the NTE in supporting the 
ejection of the tri-snRNP-specific proteins (including Prp1) from the spliceosome during 
the Complex B to Complex Bact transition. Further genetic experiments and high 
resolution structural data of the NTE in the tri-snRNP will greatly enhance our 
understanding of the NTE’s role in spliceosome activation. 
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Crystallization of the U5 snRNP and the U5.U4/U6 tri-snRNP would provide 
insight into the NTE’s orientation in these complexes. Preparing crystals suitable for 
structural analysis may be a more approachable goal than crystallization of the catalytic 
core, for several reasons. First, two other snRNPs have been crystallized, albeit with the 
removal of some associated protein and RNA regions that likely impaired crystallization. 
The human U1 snRNP has been crystallized using two separate methods (Pomeranz 
Krummel, Oubridge et al. 2009, Weber, Trowitzsch et al. 2010), and the U4 snRNP core, 
without U4-specific proteins, was crystallized from recombinant components (Leung, 
Nagai et al. 2011), providing a proof of concept for U5 snRNP crystallization Also, the 
U5 snRNP has two forms – a cytoplasmic form with Aar2, and a larger nuclear U5 
snRNP in which Brr2 has replaced Aar2 (Weber, Cristao et al. 2011). Aar2 bound to 
~1000 residues of Prp8 has already been crystallized (Galej, Oubridge et al. 2013). U5 
snRNPs and U5.U4/U6 tri-snRNPs are present in HeLa and S. cerevisiae splicing extracts, 
without the further manipulation required to form and isolate catalytically active 
spliceosomes, and these complexes have already been successfully isolated and analyzed 
by 3D EM (Sander, Golas et al. 2006, Hacker, Sander et al. 2008).  
 
Discovering the NTE’s structure and origin 
Our studies are the first to experimentally characterize the NTE’s structure. Our 
biophysical methods uncovered regions of both structure and disorder in the recombinant 
NTE and provided insight regarding the secondary structure content of the domain. From 
several standpoints, it will be useful to pursue the generation of a high-resolution model 
of the NTE’s structure. It is worth noting that, because the NTE contains some regions of 
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disorder, a binding partner may be necessary to provide a disorder-to-order transition that 
makes crystallization possible. First, the primary sequence of the NTE provides no clues 
as to what tertiary structure may be formed by the NTE. Structural data may thus unveil a 
new relationship between the primary sequence and either previously characterized or 
unique folds. Second, the tertiary structure may provide clues as to what type of 
molecules the NTE binds. In vitro RNA binding assays may be useful in determining if 
the NTE is a nucleic acid binding domain. Finally, having high-resolution structural data 
may lead to a hypothesis about the NTE’s origins. Prp8, Cwf10’s binding partner, has 
recently been shown to contain domains adapted from diverse sources. A set of domains 
in Prp8 resembles those of a fungal group II intron reverse transcriptase (Galej, Oubridge 
et al. 2013), while another domain was identified in deubiquitylating enzymes (Pena, Liu 
et al. 2007). Cwf10 is also a protein adapted from another system, as the bulk of Cwf10 is 
highly homologous to the eukaryotic ribosomal translocase EF2, at least at a primary 
sequence level (Fabrizio, Laggerbauer et al. 1997). It will be interesting to find out if the 
NTE is a known, but unrelated, domain that was fused to EF2 for the coupling of certain 
functions in the splicing process. 
It may also be worth exploring the role of phosphorylation on the structure of the 
NTE. Several large-scale screens have identified phosphorylation sites on the S. 
cerevisiae and human NTEs (Li, Gerber et al. 2007, Albuquerque, Smolka et al. 2008, 
Olsen, Vermeulen et al. 2010, Rigbolt, Prokhorova et al. 2011), although no 
phosphorylated residues have been identified on the S. pombe NTE. It would be 
interesting to perform biophysical experiments, as in Chapter II, on phosphorylated and 
non-phosphorylated NTE to determine if phosphorylation acts as a switch for different 
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conformational arrangements, as it does with F-BAR protein Cdc15 (Roberts-Galbraith, 
Ohi et al. 2010). 
 
Conclusion 
In sum, our analyses of S. pombe Cwf10 NTE have helped to define its structural 
characteristics and its contributions to multiple steps of splicing. We expect this work 
will encourage further study of the NTE to determine the specific mechanisms it employs 
as a domain in the U5 snRNP and near the heart of the spliceosome.  
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APPENDIX A 
 
EFFECTS OF VARIOUS STAINS AND TECHNIQUES ON ELECTRON 
MICROSCOPY IMAGE QUALITY OF A NEGATIVE STAIN PROTEIN SAMPLE 
 
Purpose and Methodology 
 
There are multiple heavy-metal stains used to coat biological specimens for 
imaging by transmission electron microscopy. Among those used to prepare stained grids 
of protein solutions, some of the more common are uranyl acetate, uranyl formate, 
phosphotungstic acid (PTA), ammonium molybdate, methylamine tungstate (NanoW), 
and methylamine vanadate (NanoVan). Additionally, staining qualities can be greatly 
influenced by the method of staining, including the steps of sample application, stain 
application, and stain removal/drying. While there are many other variables that influence 
staining qualities, I chose to investigate stain type and method of staining using a protein 
sample commonly used in EM characterization in our lab, Helicobacter pylori 
vacuolating toxin VacA, a 88-kDa monomer that oligomerizes, forming wheel-and-rod 
shape structures. All staining was performed on September 21, 2011. 
 
Sample 
VacA was obtained from the Tim Cover lab (Christian Gonzalez) in solution at 
650 µg/ml. The protein was diluted to 108 µg/ml using 10 mM HEPES pH 7.9 and 
applied to grids. 
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 Stains 
PTA 
2% PTA in water was made and refrigerated a few days before use. Stain solution has a 
shelf life of roughly three weeks. Purchased from Ted Pella (#19402). 
Uranyl formate 
0.7% weight/volume uranyl formate was prepared as per normal Melanie Ohi lab 
protocol. Stain was used the day of preparation and stored in a foil-wrapped tube to 
protect from light. Purchased from Polysciences, Inc. (#24762). 
NanoW 
NanoW was used as supplied in solution. Purchased from Nanoprobes (#2018-5ML). 
NanoVan 
NanoVan was used as supplied in solution. Purchased from Nanoprobes (#2011-5ML). 
 
Methods of staining 
Note that grids were not washed with buffer after sample application except in the case of 
the Melanie Ohi method and the Jim Stoops method with NanoW. 
Melanie Ohi (modified) 
Sample was applied to a glow-discharged grid and allowed to sit for two minutes. Sample 
was wicked from grid, and the grid was whisked in a small drop of buffer on parafilm. 
Buffer was wicked and grid was whisked again in buffer. Buffer was wicked and grid 
was whisked in a small drop of stain. Stain was wicked and grid was placed on top of a 
small drop of stain for 90 seconds. Stain was wicked and grid was air-waved dry. 
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Jim Stoops (also known as “deep staining”) 
A glow-discharged grid was held in forceps for the entire procedure. Sample (6 µL) was 
applied to the grid and allowed to sit 30-60 seconds. Sample was wicked from grid, with 
a small amount of sample allowed to remain on the grid. Immediately, 6 uL of stain was 
placed on the grid and wicked away. This step was repeated once more. Immediately 6µL 
of stain was placed on the grid and allowed to stand for 30-60 seconds and then wicked 
away. Grid was immediately air-waved dry. The grid was never allowed to dry 
completely between sample application and the final drying step. 
Roger Craig (also known as the “Brandeis method”) 
Sample was applied to a glow-discharged grid held in forceps and allowed to sit for two 
minutes. Stain was loaded in a disposable bulb pipette. Forceps were held vertically with 
the grid end pointing towards floor. The pipette was held at 15-20 degrees from the 
vertical forceps with the pipette tip very near the grid. The grid was washed with stain by 
applying 4-6 continuous drops. The last drop was allowed to remain on the grid 30-60 
seconds with the forceps returned to a flat surface. Stain was wicked away and the grid 
was waved in the air to dry. 
Reactive buffers (named because of its successful use with sample in buffers that, with 
other methods, stains poorly) 
Three drops of stain (150 µL each) were applied to parafilm. Sample (5 µL) was applied 
to a glow-discharged grid and allowed to sit 30-60 seconds. Grid was placed on top of the 
first stain drop, then moved to the second, and third drops. Grid was allowed to sit on top 
of the third stain drop for 30 seconds. Stain was wicked from the grid, and the grid was 
immediately air-waved dry. 
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 Results and discussion 
Representative images are shown for uranyl formate (Figure A-1), PTA (Figure 
A-2), NanoW (Figure A-3), and NanoVan (Figure A-4). These images have high 
background, likely due to the presence of VacA monomers (Yoshimasa Takizawa, 
personal communication). VacA oligomers were very clear under most combinations of 
stain/method except for the uranyl formate/reactive buffers combination, which produced 
fuzzy images with unusually high background (data not shown). Under some conditions, 
a variable depth of stain could be found on a single grid (for example, NanoW using the 
Jim Stoops method, Figure A-3A, B, and C). Side views of the oligomers were seen 
under several conditions (e.g. Figure A-1A and Figure A-2C). 
Although uranyl formate is a good general purpose stain (Ohi, Li et al. 2004), it 
has been suggested that each protein sample will react differently to both stain and 
staining conditions (Radermacher, Ruiz et al. 2006 and Teresa Ruiz, personal 
communication). Therefore, it may be advisable to test a protein sample with different 
stains and staining conditions to obtain optimum particle images, which should positively 
influence all downstream processing steps in single-particle analysis. 
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Uranyl formate - Melanie Ohi method
FIGURE A-1
Uranyl formate - Jim Stoops method
Uranyl formate - Jim Stoops method Uranyl formate - Roger Craig method
Uranyl formate - Roger Craig method Uranyl formate - Roger Craig method
A B
C D
FE
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FIGURE A-1 (continued)
Images of VacA stained with uranyl formate using various methods
VacA protein solution was stained with uranyl formate using the indicated method and 
imaged on an FEI Morgagni microscope at 28,000X. Images of the same stain/method are 
grouped together and color-coded. Scale bars represent 100 nm.
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PTA - Jim Stoops method PTA - Jim Stoops method
PTA - Jim Stoops method
PTA - reactive buffers method
PTA - reactive buffers method
FIGURE A-2
Images of VacA stained with PTA 
using various methods
VacA protein solution was stained with 
phosphotungstic acid (PTA) using the indicated 
method and imaged on an FEI Morgagni 
microscope at 28,000X. Images of the same 
stain/method are grouped together and color-
coded. Scale bars represent 100 nm.
A B
C D
E
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NanoW - Jim Stoops method
NanoW - Jim Stoops method NanoW - Jim Stoops method
FIGURE A-3
Images of VacA stained with NanoW
VacA protein solution was stained with methylamine tungstate (NanoW) using the Jim
Stoops method and imaged on an FEI Morgagni microscope at 28,000X. 
Scale bars represent 100 nm.
A B
C
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NanoVan - Jim Stoops methodNanoVan - Jim Stoops method
A B
FIGURE A-4
Images of VacA stained with NanoVan
VacA protein solution was stained with methylamine vanadate (NanoVan) using the Jim
Stoops method and imaged on an FEI Morgagni microscope at 28,000X. 
Scale bars represent 100 nm.
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APPENDIX B 
 
CONTRIBUTIONS OF NTC COMPONENTS TO DNA DAMAGE PHENOTYPES 
 
Introduction 
The NTC, as described in Chapter I, is a protein sub-complex of the spliceosome. 
While the NTC has a well-documented role in splicing, early evidence pointed to a role in 
DNA damage repair (Grey, Dusterhoft et al. 1996). While a DNA damage phenotype 
could arise secondarily from a splicing defect (discussed below), there has been an 
accumulation of evidence that NTC components function directly in DNA damage repair 
(reviewed in Legerski 2009, Chanarat and Strasser 2013). Such evidence comes primarily 
from yeast two-hybrid studies and other physical association data of NTC members with 
proteins involved in DNA damage repair. Kuraoka, et al., showed that human NTC 
member SYF1 interacts with xeroderma pigmentosum group A protein (XPA) and other 
transcription-coupled repair factors (Kuraoka, Ito et al. 2008). Budding yeast Prp19 
associates with an endonuclease required for nucleotide excision repair (Revers, Cardone 
et al. 2002), and human Cdc5L interacts physically with DNA damage checkpoint protein 
ataxia-telangiectasia and Rad3-related (ATR) (Zhang, Kaur et al. 2009). 
Despite these direct links, it is reasonable to suggest that inoperative spliceosome 
proteins will, through a splicing mechanism, impair the proper expression of some or all 
DNA damage repair factors, especially in higher eukaryotes where most genes contain 
introns. Additionally, the close proximity of splicing factors to genomic DNA during co-
transcriptional splicing may present an opportunity to damage DNA: Li and Manley 
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demonstrated that knockdown of SR splicing factor ASF/SF2 led to R loop formation, 
leading to DNA damage (Li and Manley 2005). In their model, the presence of ASF/SF2 
normally keeps the nascent RNA away from the vulnerable single strands of the DNA. 
When ASF/SF2 is not present, the transcript forms a hybrid with its single-strand DNA 
template (an R loop). This DNA/RNA hybrid can cause double-stranded breaks wherever 
transcription is taking place, and it can activate DNA damage repair checkpoints. 
Because ASF/SF2 is a non-NTC splicing factor whose loss can cause the appearance of 
DNA damage repair defects, we wondered whether the NTC truly is a DNA damage 
repair component, or whether NTC-associated DNA damage phenotypes could be due to 
interference with NTC’s splicing function.  
 
Results and discussion 
To address this issue, we chose to investigate DNA damage and mitotic defect 
phenotypes in HeLa cells. By siRNA-depleting three NTC components, PRP19 (homolog 
of S. cerevisiae Prp19), PLRG1 (S. cerevisiae Prp46), and CDC5L (S. cerevisiae Cef1), 
and two non-NTC spliceosome RNA helicases, U5-200 (S. cerevisiae Brr2) and DHX8 (S. 
cerevisiae Prp22), we hoped to determine if the DNA damage phenotypes were different 
between NTC components and other spliceosome proteins. 
Cells were transfected by siRNAs or a no-siRNA control for 72 hours. Cells were 
fixed and probed with an antibody against γ-H2AX, a genome-bound indicator of DNA 
damage. Twenty-five cells per siRNA were quantified for the amount of fluorescence 
signal. All siRNA-treated cells displayed increased levels of γ-H2AX, compared with 
empty-transfected control (Figure B-1A), indicating that the NTC and non-NTC splicing 
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A γ-H2AX immunofluorescence per cell
B
C
FIGURE B-1
siRNAs targeting NTC and other spliceosome components cause DNA damage
A) HeLa cells transfected with the indicated siRNAs for 72 hours were stained by anti-
γ-H2AX, and the fluorescence intensity per cell was quantified. The value represents the 
average per-cell intensity. The error bar represents the standard error of the mean. At least 
25 cells per condition were quantified. B) As in A, except that cells were stained for DNA by 
Hoechst, and >120 cells per genotype were counted. Values represent the percentage of 
cells with a micronucleation phenotype. C) HeLa cells were treated with 2mM hydroxyurea 
for four hours, fixed, and stained for γ-H2AX (magenta) and PRPF19 (green; Abcam 
ab27692). The bottom panel is an overlay in which co-localization is indicated by
white. Scale bar represents 10 μm.
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factors’ depletion caused DNA damage. Although every NTC component had a higher 
per cell value than the two non-NTC components, statistical significance of the 
differences among the siRNA-treated cells was not determined. 
Next cells were transfected as before for 72 hours and stained with DAPI to reveal 
DNA morphology. Micronucleation was a common phenotype observed. 
Micronucleation results from errors in chromosome segregation during mitosis and is a 
result of either chromosome breakage or dysfunction in the mitotic machinery (Norppa 
and Falck 2003). We quantified the percentage of nuclei that were micronucleated 
(Figure B-1B) and saw that all of the siRNAs caused micronucleation above baseline. 
Interestingly, siRNA against CDC5L led to the largest percentage of micronucleated cells, 
while PRP19 and PLRG1 siRNAs caused the smallest. As knockdown efficiency was not 
quantified, it is not clear whether this result indicates CDC5L loss causes more 
accumulation of micronucleated cells than loss of the other tested splicing factors. 
Finally, we examined the behavior of NTC component PRPF19 under genotoxic 
stress conditions. PRPF19 distribution in nuclear speckles is not disrupted by 
hydroxyurea (HU) application (data not shown). Based on previous reports of NTC 
component physical interactions with DNA repair proteins, we examined co-localization 
of PRPF19 and γ-H2AX foci by immunofluorescence. Upon HU application, PRPF19 
does not appear to co-localize with the DNA damage marker (Figure B-1C). These results 
together suggest that most or all of PRPF19 is not recruited to DNA damage sites under 
our conditions. 
This brief set of experiments was designed to address whether NTC components 
have direct roles as DNA repair agents. We found that NTC-depleted HeLa cells had an 
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increased level of genotoxic stress; however, depleting cells of other splicing factors also 
increased genotoxic stress. Similarly, NTC and non-NTC-depleted HeLa cells underwent 
micronucleation. These results suggest that spliceosome components in general are 
important for DNA integrity; however, the results do not rule out an additional function 
specific to NTC components. The lack of co-localization of γ-H2AX foci with PRPF19 
simply indicates that PRPF19 may not be present at the time of γ-H2AX signaling, and 
does not rule out a function for the protein at a different point in the DNA repair process. 
We recommend that additional investigation focus on understanding the potential role of 
improper splicing progression in causing genomic damage. With this foundation, the non-
splicing roles of NTC members in DNA damage repair can be more thoroughly explored.  
 
Additional Methods 
Cells were transfected with HiPerFect (Qiagen) and siRNAs (Dharmacon ON-
TARGETplus SMARTpool), 20 uL of 20 uM siRNA per 10 cm dish. 
All images were taken using an Eclipse 90i (Nikon Instruments, Melville, NY) 
microscope equipped with Nikon objectives and a Cool SnapHQ2 CCD camera (Roper 
Scientific, Tucson, AZ). Immunofluorescence intensities were measured using NIS-
Elements software (Nikon Instruments). 
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APPENDIX C 
 
ISOLATING THE NTC 
 
The NTC, as described in Chapter I, is a protein sub-complex of the spliceosome. 
There have been several attempts to isolate this sub-complex from both yeast and human 
cells. Previous characterization of the NTC in S. pombe suggests it is stably integrated 
into a larger U5.U2/U6 complex under a variety of purification conditions (McDonald, 
Ohi et al. 1999, Ohi, Link et al. 2002). However, Tarn, et al., were able to isolate the 
NTC from S. cerevisiae splicing extract using HA-tagged Prp19 (Tarn, Hsu et al. 1994). 
This purification, as detected by silver stain, spanned most fractions of a density gradient, 
suggesting a homogenous NTC purification had not been achieved. Several purifications 
of the NTC from human cells have culminated in the characterization of a fairly 
homogenous seven-protein complex that was amenable to 2D EM analysis (Grote, Wolf 
et al. 2010). Isolation of the NTC would be valuable in at least two applications: 
structural characterization and functional in vitro add-back experiments. Because of the 
NTC’s integration into the catalytic and post-catalytic spliceosomes, high-resolution 
structural characterization of the NTC would enhance our understanding of spliceosome 
organization. Additionally, the isolation of a functional, homogenous NTC for use in in 
vitro splicing assays would enhance our understanding of spliceosome activation. 
In our first attempt to characterize the S. cerevisiae NTC, we modified a method 
originally described in Tarn, et al. (Tarn, Hsu et al. 1994). This involved adjusting yeast 
cell lysate to 40% ammonium sulfate and removing the precipitant prior to purifying the 
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NTC with Prp19-TAP under high salt conditions (500 mM NaCl). We called this 
purification scheme “40P” Prp19-TAP. Our normal two-step TAP purification (Gould, 
Ren et al. 2004) uses 150 mM NaCl buffers throughout the purification, and under these 
conditions Prp19-TAP associates with the U5, U2, and U6 snRNAs (Ohi, Link et al. 
2002). Interestingly, the complex appears to be less stable than the S. pombe U5.U2/U6 
complex – by negative stain EM, S. cerevisiae Prp19-TAP particles appear more 
heterogeneous and fall apart more easily than S. pombe Prp19-TAP particles (Ohi, 
unpublished observation). Additionally, in S. cerevisiae lysates, multiple NTC 
components sediment at the top of the gradient, presumably as single proteins, in addition 
to sedimenting in a large 40S complex (Ohi and Gould 2002). We hoped to capitalize on 
the less-stable nature of S. cerevisiae U5.U2/U6 and isolate only NTC proteins by the 
addition of the ammonium sulfate fractionation step. As an initial determination of 
whether we had isolated the NTC instead of the larger 40S U5.U2/U6 complex, we 
analyzed the sedimentation pattern of Cwc2-myc, a protein that directly interacts with 
Prp19 and sediments in the U5.U2/U6 complex (Ohi and Gould 2002, Vander Kooi, Ren 
et al. 2010), in sucrose gradients by Western blotting. From this analysis, we saw that 
under the 40P conditions, Cwc2-myc still sedimented in a similar manner as Cwc2 
purified under normal conditions (Figure C-1A). Analysis by mass spectrometry 
confirmed that U2 and U5 proteins were still associating with the 40P Prp19-TAP; 
however, we observed a few differences between the proteins associated with Prp19-TAP 
depending on whether the purification was done under 40P or normal conditions. 
Specifically, the 40P purification lacked Brr2 (U5 snRNP component), Lea1 (U2 snRNP 
component), and Ntc20 (NTC member) (data not shown). Finally, negative stain EM 
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AB
FIGURE C-1
Effects of ammonium sulfate extraction on spliceosome complexes
A) prp19-TAP cwc2-myc cells were lysed in NP-40 buffer (normal) or lysed in NP-40 buffer and 
then extracted with ammonium sulfate (40P). TAP-purified proteins were eluted and loaded on
to a 10-30% sucrose gradient. Fractions collected were blotted with anti-myc, revealing the
sedimentation pattern of Cwc2-myc. The “ctrl” lane was loaded with the TAP eluate. B) 
Electron micrographs of purified Prp19-TAP complexes, with normal and 40P defined as in A.
Scale bar represents 100 nm.
ctrl   1    2    3     4    5     6    7    8     9   10
normal
40P
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revealed that 40P Prp19-TAP particles were similar in size and shape to Prp19-TAP 
particles purified under normal TAP conditions (Ohi, Link et al. 2002), although with 
more rounded, less detailed densities (Figure C-1B). From these analyses, we concluded 
that the ammonium sulfate cut is unsuitable for destabilizing the NTC from larger 
spliceosome particles in S. cerevisiae lysates.  
In a second attempt to characterize the S. cerevisiae NTC, we made whole cell 
splicing extract (WCSE) from prp19-TAP cwc2-myc cells using methods described in 
both Ansari and Schwer 1995 and Umen and Guthrie 1995. WCSE is prepared by a lysis 
and dialysis protocol different from our lab’s normal native cell lysate protocol (Gould, 
Ren et al. 2004). As a first analysis, we characterized the sedimentation pattern of Cwc2-
myc under these new conditions, without immunopurification (Figure C-2A). 
Promisingly, cells lysed using the WCSE approach had much more Cwc2-myc in low 
molecular weight fractions than did lysate made using our lab’s normal protocol. Further 
adjustment of the WCSE to splicing conditions (final concentrations: 100 mM potassium 
phosphate, 5 mM magnesium chloride, 1.67 mM spermidine, and 5% PEG) with or 
without ATP caused an additional shift of Cwc2-myc away from higher molecular weight 
fractions (top of gradient) to lower molecular weight fractions (bottom of gradient). SDS-
PAGE separation and silver stain analysis of purified Prp19-TAP from WCSE and 
WCSE under splicing conditions revealed markedly different band patterns than what 
was seen from Prp19-TAP lysed under conditions described in Ohi, et al. (Ohi, Link et al. 
2002) (Figure C-2B). Finally, in an attempt to examine the structural homogeneity of 
these smaller NTC-containing complexes, we purified Prp19-TAP from WCSE and ran 
the eluted complex over a sucrose gradient under identical conditions to Figure C-1A, 
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AB
FIGURE C-2
NTC characterization in S. cerevisiae whole cell splicing extracts
A) prp19-TAP cwc2-myc cells were lysed in NP-40 buffer (lysate) or prepared as whole cell
splicing extract (WCSE). WCSE was used in a splicing reaction without an added
transcript and with (spl +ATP) or without (spl -ATP) ATP. These preparations were run on a 10-
30% sucrose gradient and probed with anti-myc. B) Silver stain of Prp19-TAP purifications.
Column descriptions are as in A. Purifications from lysate and WCSE were two step TAP
procedures, while purifications from spl -ATP or +ATP were one step Dynabead-IgG procedures
with subsequent elution with TEV protease (TEV). Molecular weight markers (left) are in kDa. 
C) top - Prp19-TAP was purified from WCSE and run on a glycerol gradient as in A, but with 
glutaraldehyde. Electron micrograph is of fraction 15. Scale bar represents 100 nm. bottom - 
Class averages of WCSE fraction 15 particles. Numbers indicate the number of particles in
each class. Scale bar represents 10 nm.
blot: anti-myc
1    2    3     4    5     6    7    8     9   10       11  12   13  14  15  16   17   18  19   20
66.3
55.4
36.5
31
21.5
top (10%)bottom (30%)
lysate
WCSE
spl -ATP
spl +ATP
lys
ate
WC
SE
sp
l -A
TP
sp
l +
AT
P
Prp19-CBP/
Prp19-TAP
TEV
C
1153 243 938 26 1842
Cwc2-myc
Cwc2-myc
Cwc2-myc
Cwc2-myc
            102
AB
FIGURE C-3
Prp19 characterization in vertebrate model systems
A) Xenopus laevis egg extracts were run over a 10-30% sucrose gradient. Fractions were
collected and blotted with anti-Prp19. Molecular weight markers (left) are in kDa. The observed 
top and bottom bands of Prp19 are indicated by arrows (right). B) Egg extracts were incubated 
with Affi-Prep protein A beads (Bio-Rad) conjugated to either rabbit IgG (Jackson Labs) or anti-
Prp19. Washed beads were eluted by SDS and run on a gel. Silver stain and the possible 
location of the Prp19 band are shown. Molecular weight markers (left) are in kDa. C) HeLa cells 
were harvested after growth in serum-containing media (asynchronous) or after 15.5 hours in 
media with 10μM STLC (mitotic arrest). IPs, gels, staining, and markers are as in B.
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except that the gradient contained glutaraldehyde as in the Grafix protocol (Kastner, 
Fischer et al. 2008). WCSE fraction 15 was imaged by negative-stain EM and showed 
detailed, yet heterogeneous particles (Figure C-1C, top). 4,202 particles were aligned to 
produce class averages using the software SPIDER. Although multiple processing 
parameters were tried, no good class averages could be obtained (Figure C-1C, bottom). 
Next, we examined Prp19-associated proteins in Xenopus laevis egg extracts and 
HeLa cell lysates. Xenopus egg extracts appeared to contain two forms of Prp19 by 
Western blot, with one form predominant in high molecular weight fractions, and the 
other form in low molecular weight fractions (Figure C-3A, arrows). The identities of 
these two forms are unknown, but could indicate the presence of a modification, such as 
phosphorylation. Anti-human Prp19 antibody (Abcam ab27692) was used to 
immunoprecipitate Prp19 from the egg extracts (Figure C-3B), and both asynchronous 
and mitotic HeLa cells (Figure C-3C). Silver staining of all anti-Prp19 IPs clearly showed 
the presence of a band near the predicted molecular weight of Prp19 (55 kDa), and 
additional bands unique to the anti-Prp19 beads at 90-110 kDa could indicate a co-
purifying NTC protein, such as CDC5L. The next step would be to analyze these 
purifications using mass spectrometry to determine which proteins are associating with 
Prp19. However, these initial results indicate that it may be possible to purify the NTC 
from either X. laevis or HeLa cell extracts.  
Together, these results indicate that a homogenous NTC complex could possibly 
be isolated from the WCSE from yeast, even though our efforts have not yet been 
successful. It will be interesting to see if the human NTC identified in Grote, Wolf et al. 
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2010 can successfully be characterized by 3D EM, or if the proteolysis-resistant NTC 
core identified in the same work can be crystallized. 
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APPENDIX D 
 
CYCLOPHILINS IN FISSION YEAST SPLICING 
 
While there have been many functions attributed to enzymes such as kinases, 
RNA helicases, and GTPases in splicing, the functions of peptidyl-prolyl cis-trans 
isomerases (PPIases) are less clear. While most peptide bonds in biological systems are 
synthesized in the lower energy-state trans state, the bond preceding proline often occurs 
in cis, and can be interconverted to trans. The PPIases accelerate this proline 
isomerization, and targeted isomerization is an important regulatory mechanism for 
processes such as cell signaling and gene expression (see Introduction, Lu, Finn et al. 
2007). There are at least eight PPIases that have been found by mass spectrometery to be 
associated with spliceosome components, almost all of them belonging to a sub-class of 
PPIases, cyclophilins, that generally have high affinity for the immunosuppressive drug 
cyclosporin A (Wang and Heitman 2005). While the spliceosome-associated cyclophilins 
show conservation of sequence amongst species, most of these cyclophilins have been 
lost from Saccharomyces cerevisiae, a common model organism used to study splicing. 
Interestingly, five of the eight spliceosome-associated cyclophilins (cyps) are present in 
the yeast Schizosaccharomyces pombe, and include Cyp1, Cyp8, Cyp9, Rct1, and Cwf27 
(Figure D-1A). S. pombe Rct1 regulates phosphorylation of specific residues on RNA 
polymerase II’s C-terminal domain (Gullerova, Barta et al. 2007). Cyp1 and Cwf27 have 
been found to associate with S. pombe U5.U2/U6 spliceosomes (Ohi, Link et al. 2002, 
Ren, McLean et al. 2011); however, no function has been associated with these proteins. 
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To further investigate the role of PPIases in the splicing reaction, we chose to examine S. 
pombe Cyp1, Cyp9, and Cwf27. 
To confirm that these proteins are localized in the nucleus, we first attempted to 
C-terminally tag the endogenous loci of cyp1, cyp9, and cwf27. Live-cell imaging of 
GTP-tagged strains shows a strong, nuclear signal, indicating that the proteins are stable 
when tagged (Figure D-1B). We then performed TAP purifications using cyp1-TAP, 
cyp9-TAP, and cwf27-TAP strains. SDS-PAGE analysis followed by silver-staining of 
Cyp1-TAP bore a striking resemblance to the staining of Cwf2-TAP (Figure D-2A, lanes 
3 and 1, respectively). Mass spectrometry analysis of Cwf2-TAP shows a similar protein 
composition to the U5.U2/U6 spliceosome (Ren, McLean et al. 2011). Additionally, the 
Cyp1-TAP and Cwf2-TAP negative-stain EM preparations showed particles of similar 
size and shape (Figure D-2B). 
Similar characterization of the Cwf27-TAP and Cyp9-TAP purifications showed 
only a few bands by silver stain (Figure D-2A lanes 2 and 4), and no recognizable 
particles by EM (data not shown). Because the Cyp9-TAP purification yielded a strong 
band around the size expected for the bait protein (Figure D-2A “Cyp9-CBP”), it is likely 
that the Cyp9-TAP protein is stable but does not form strong associations with 
spliceosomes. Since Cwf27-TAP’s expression was not confirmed by Western blot, and 
because there is no band near Cwf27-CBP’s predicted molecular weight (Figure D-2A 
lane 2), these data are ambiguous as to whether Cwf27 was tagged improperly in this 
strain, or if the purification failed for technical reasons. 
We next attempted to determine binding partners of Cwf27 using yeast two-
hybrid analysis. Cwf27 contains a homolog in S. cerevisiae, Cwc27, which has been 
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FIGURE D-1
Cyclophilin homologs and localization of GFP-tagged cyclophilins
A) Eight human spliceosome-associated cyclophilins are listed along with their homologs in
fission and budding yeast. B) Cells were grown at room temperature and imaged live by DIC and 
a GFP channel. Positioning in the merge column is not accurate due to cell movement between 
the two imaging modes.
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BFIGURE D-2
Purification of cyclophilins from native lysates
A) Purifications of the indicated proteins were run on a 4-12% Bis-Tris SDS-PAGE gel and silver 
stained. Molecular weight markers are indicated on the left in kilodaltons. Protein names to the 
right of the gel indicate the predicted position of the bait fused to calmodulin binding protein 
(CBP). B) Purifications of the indicated proteins were negatively stained and imaged using an 
FEI Morgagni microscope at 100 kV. Scale bar represents 100 nm.
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screened for genetic interactions in several large-scale studies. The interactions known 
with other spliceosome proteins were used to prepare targeted Y2H vectors for testing 
with Cwc27, and included the three subunits of the RES complex (Ist3, Bud13, and 
Pml1). Additionally, we tested two-hybrid interactions between Cwc27 and NTC 
components, for which vectors were readily available in our lab. Through this analysis, 
we found no positive interactions between Cwc27 and members of the RES and/or NTC 
complexes. 
Next, we searched for potential dominant-negative growth effects by 
overexpression of the wild-type genes. We cloned either cyp1 and cwf27 cDNA into the 
pREP3X vector, as cyp9 cDNA could not be isolated. Growth of strains carrying these 
vectors were not significantly reduced at 16, 25, or 37°C (Figure D-3A). However, spot 
assays, which can detect more subtle changes in growth, were not performed. 
We investigated the effects of removing cyp1, cyp9, and cwf27 from haploid S. 
pombe cells. Cells carrying the single deletions were viable and grew similar to wild-type 
at 25, 32, and 37°C (Figure D-3B). Additionally, the triple knockout strain cyp1::ura4+ 
cyp9::ura4+ cwf27::ura4+ grew well at 25 and 37°C (Figure D-3C). From observation of 
live cells, it was unclear whether or not the triple mutant had abnormal cell morphology 
or length (data not shown), and cell length quantification was not performed. 
Because of Cyp1’s strong association with a possible spliceosome complex 
(Figure D-2A), we tested the cyp1::ura4+ deletion strain for synthetic interactions with 
six known splicing alleles, cdc5-120, cwf11Δ, dre4Δ, prp1-1, prp4-73, and prp5-1. All 
double mutant strains were viable and showed no synthetic sick interactions when grown 
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FIGURE D-3
Cyclophilin overexpression and deletion phenotypes
A) Wild-type cells were transformed with the pREP3X vector (empty) or with the indicated
cyclophilin cDNA in pREP3X. Cells were grown at 25 on plates selecting for the plasmid
and either repressing cyclophilin expression (MAU with 18.9μM thiamine) or expressing the
cyclophilin (MAU). A pair of separate transformants was streaked for each genotype. B)
Cells of the indicated genotypes were spotted on to YE plates at the indicated temperatures.
C) Wild-type and cyp1∆ cwf27∆ cyp9∆ strains were streaked on to YE plates at the
indicated temperatures. D) Single and double mutant strains were streaked on to YE at the
indicated temperatures.
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on YE at 25 and 32°C (Figure D-3D). Spot assays, which can detect more subtle changes 
in growth, were not performed. 
From these experimental data, the only strong evidence for the involvement of 
any of these cyclophilins in splicing is the co-IP of a spliceosome-resembling particle by 
Cyp1-TAP (Figure D-2B). However, from my analysis, the enzymatic activity of these 
proteins does not seem to be important the splicing reaction, since even the triple 
knockout does not cause loss of cell viability. Although not essential for splicing, it is 
possible that the cyclophilins may be important for efficient splicing. One simple 
experiment to address this possibility would be to isolate cellular RNA from a wild-type 
control strain, each single deletion strain, and the triple-deletion strain and use RT-PCR 
analysis to determine if there is an accumulation of unspliced RNA in these strains.  
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APPENDIX E 
 
MATERIALS AND METHODS 
 
Strains, yeast methods, and molecular biology 
Strains used in this study are listed in Table 1 of this appendix. Yeast strains were 
grown in yeast extract (YE) media or Edinburgh minimal media with appropriate 
supplements. The spp41-1 (Schmidt, Richert et al. 1999) and spp42-1 (Schmidt, Richert 
et al. 1999) ORFs were tagged endogenously at the 3’ end with kanMX6 for genetic 
analyses as previously described (Bähler, Wu et al. 1998). Transformations were done as 
described (Keeney and Boeke 1994) for all tag insertions, gene replacements, and 
introduction of plasmids. Integration of tags was verified using whole-cell PCR and 
immunoblot analysis as appropriate. Crossing of tagged and mutated loci into other 
strains was accomplished using standard S. pombe mating, sporulation, and tetrad 
dissection techniques. For spot assays, cells were grown to midlog phase at 25°C and 
resuspended in water to achieve an equal OD595 value. 10-fold serial dilutions were made, 
and 2.5 µl of each dilution was plated on YE. Plates were incubated at the indicated 
temperatures for 2-9 days before imaging. 
For induction of the nmt3X promoter (Maundrell 1993), the cells were first grown 
overnight in media containing 5 µg/ml of thiamine, then washed three times with media 
lacking thiamine and allowed to grow for at least 16 hours in thiamine-free media. For 
harvesting smaller cultures, the growth in 5 µg/ml of thiamine was omitted. 
Overexpression plasmids used include pREP3X cwf10 1-135 (pOHI1038), pREP3X 
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cwf10 1-107 (pOHI1037), pREP41 NTAP (Tasto, Carnahan et al. 2001) (pOHI756), 
pREP41 NTAP-cwf10 2-135 (pOHI1039), and pREP41 NTAP-cwf10 2-26 (pOHI1076).  
All plasmids were generated by standard molecular biology techniques. For gene 
replacements at the endogenous cwf10+ locus, mutant open reading frames were 
generated using QuikChange II or QuikChange Lightning Multi technologies (Agilent 
Technologies, Santa Clara, CA). The mutant ORF and at least 500 bp of 5’- and 3’-
flanking nucleotides were subcloned into the pIRT2 plasmid containing the LEU2 marker. 
A diploid cwf10+/cwf10::ura4+ strain was transformed with pIRT2–cwf10 mutant 
constructs and grown on minimal media lacking leucine, adenine, and uracil. 
Transformants were allowed to sporulate and stable haploid integrants were selected 
based on resistance to 5-FOA. Mutants were validated by whole-cell PCR with primers 
outside of the 5’- and 3’-flanking regions. pIRT2-cwf10 mutant plasmids used include 
pOHI1035 (2-135Δ), pOHI978 (2-127Δ), pOHI1071 (2-23Δ), and pOHI1070 (E/D-A). 
Liquid culture cell numbers were counted with a Z1 Coulter Counter (Beckman 
Coulter, Brea, CA) as previously described (Ohi, McCollum et al. 1994). 
 
Random mutagenesis of cwf10+: 
A kanMX6 cassette was inserted 3’ of the cwf10+ gene using OHI plasmid 725 
and a previously described method (Bähler, Wu et al. 1998). The genomic region 
encompassing 500 bp upstream and downstream of cwf10+::cwf10-kanMX6 was 
amplified by PCR. Error-prone PCR mutagenesis was performed on this template, 
essentially as described (Wilson and Keefe 2001). Briefly, the PCR reactions (300uL) 
contained 1X Taq buffer without magnesium chloride (NEB), 7 mM magnesium chloride, 
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0.5 mM manganese chloride, 0.2 mM dATP and dGTP, 1 mM dTTP and dCTP, 2 µM 
each primer, variable amounts of PCR template, and 15 units Taq polymerase (NEB). 
Full length cwf10: Reactions were split among several tubes and incubated under PCR 
cycling parameters: 30 sec at 95°C; 8 or 15 cycles of 30 sec at 95°C, and 7 min at 68°C; 
and 8 min at 68°C.  C-terminal cwf10:  Reactions were split among several tubes and 
incubated under PCR cycling parameters: 30 sec at 95°C; 15 cycles of 15 sec at 95°C, 
and 4 min at 68°C; and 8 min at 68°C. Reactions were recombined, the amplicon gel 
extracted or simply run through a DNA spin column, and transformed into strain OHI246. 
Transformed cells were plated on several YE plates, placed at 25°C, and the next day 
replica plated to YE + G418 at 25°C to select for transformants. Strains were then tested 
for conditional lethality by replica plating to YE and incubating at 36°C for several days. 
Several hundred clones were screened and nine clones (cwf10-2 through cwf10-10) were 
chosen for further characterization. To determine the mutation locations, genomic DNA 
was prepared from each strain, the cwf10 gene was PCR amplified, and the PCR product 
was directly sequenced. 
 
Antibody preparation 
His6-Cwf10 (673-983) was expressed in E. coli BL21(DE3) cells (EMD Millipore, 
Battymarch Park, MA), purified with HisPur Cobalt agarose (Pierce/Thermo Scientific, 
Rockford, IL), and used to immunize rabbits (Cocalico Biologicals, Reamstown, PA). 
Cwf10-specific antibodies were affinity purified over NHS-activated sepharose fast flow 
4 (GE Healthcare Life Sciences, Piscataway, NJ) covalently linked to His6-Cwf10 (673-
983). 
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Immunoprecipitations, immunoblotting, and sucrose gradients 
“Native” and “denatured” whole-cell lysates were prepared as previously 
described, with leupeptin omitted from lysis buffers (McDonald, Ohi et al. 1999). For 
immunoblots, proteins were resolved by 10% SDS-PAGE (lysates except Brr2-HA), 4-
12% Bis-Tris PAGE (Brr2-HA lysates), or 8% SDS-PAGE (lysate gradients) and 
transferred by electroblotting to a Protran nitrocellulose membrane (Whatman, GE 
Healthcare, Piscataway, NJ). Primary antibodies/antisera used include: anti-Cdc5 
(1/5,000) (McDonald, Ohi et al. 1999) and anti-Asp1 (1/5,000) rabbit polyclonal antisera, 
anti-Cwf10 affinity purified rabbit polyclonal antibody (0.84 µg/ml), and anti-PSTAIR 
(detects S. pombe Cdc2) monoclonal antibody (1/10,000) (Sigma, St. Louis, MO). For 
some of the Cwf10 quantification, the antiserum was used instead of the antibody. Anti-
myc (9E10, 0.3 µg/ml) and anti-HA (12CA5, 1 µg/ml) mouse monoclonal antibodies 
were used to detect Myc- and HA-tagged proteins, respectively. Primary antibodies were 
detected by secondary antibodies AlexaFluor 700 (Invitrogen, Life Technologies, Grand 
Island, NY) or IRDye 800CW (LI-COR Biosciences, Lincoln, NE) (1/10,00 dilution), 
and visualized and quantified using an Odyssey scanner and software (LI-COR 
Biosciences).  
For gradients, a 15OD pellet was lysed and a 200 µl volume corresponding to 
25% of the lysate was layered onto a 10 to 30% sucrose gradient and centrifuged at 
25,000 RPM at 4°C for 16 h in a SW55Ti rotor (Beckman). Fractions from the gradients 
were collected manually and (a) TCA precipitated and resuspended in SDS sample buffer 
to detect protein or (b) extracted with 5:1 acid phenol:chloroform and resuspended in 
TBE-urea sample buffer (Life Technologies, Grand Island, NY) to detect RNA. Parallel 
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standard gradients contained thyroglobulin (19 S) and catalase (11.35 S) (HMW 
calibration kit; GE Healthcare, Piscataway, NJ) or 20% of lysate from a 20 OD pellet of 
FAS2-V5 tagged S. cerevisiae (strain OHI375) (40 S marker). 
Co-IPs for Western blot analysis were performed as in (Ren, McLean et al. 2011). 
TAPs (Tandem Affinity Purifications) were performed as described (Gould, Ren et al. 
2004), with the following modifications: native lysis buffer was as described earlier in 
this section, calmodulin binding volume was reduced by 3 ml, CBB washes were 10 ml 
and 2 ml, respectively, and the final CBB buffer and the CEB buffer contained no 
detergent. For TAPs analyzed in Table 2-1 purifications were done using 75 mM NaCl. 
 
RNA isolation, Northern blotting, and RT-PCR 
Total RNA was prepared from cells by extraction with hot acidic phenol as 
described previously (Collart and Oliviero 2001). To visualize snRNAs either found in 
fractions collected from sucrose gradients or from NTAP-NTE and anti-snRNA cap 
(antitrimethylguanosine [m3G], Millipore), RNAs were resolved using 6% Tris-Borate-
EDTA–Urea gels (Life Technologies). RNA was transferred to a Duralon-UV membrane 
(Agilent Technologies, Santa Clara, CA), UV cross-linked using energy setting 700 
(UVC500 crosslinker; GE Healthcare, Piscataway, NJ), and detected by using γ-32P ATP 
(PerkinElmer, Waltham, MA) labeled oligonucleotides complementary to S. pombe U1, 
U2, U4, U5, and U6 (for sequences see Table 2 of this appendix). Blots were exposed to 
phosphorimager screens for 14-18 hours and visualized using Typhoon 9200 or FLA-
7000IP instruments (GE Healthcare, Piscataway, NJ). Quantification for snRNAs found 
in fractions collected from sucrose gradients was performed using ImageQuant TL 8.1 
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(GE Healthcare). For RT-PCR analysis, RNA was treated with DNase I (Life 
Technologies) and reverse transcribed according to the manufacturer’s directions using 
random hexamers for priming (SuperScript; Life Technologies). 800 ng of RNA was 
used for each reaction. Three technical samples per genotype were processed. The 
resulting cDNA was PCR-amplified with tbp1_a or mrps16_b primers (Table 2, this 
appendix) for 27 cycles, and ethidium bromide-stained gels were imaged within a linear 
range and quantified with ImageQuant TL 8.1 (GE Healthcare). 
 
RNA sequencing and analyses 
Replicates were grown together and processed separately for all following steps. 
The Vanderbilt Technologies for Advanced Genomics Core Facility (VANTAGE, 
Nashville, TN) used the TruSeq Stranded mRNA Sample Preparation Kit (Illumina, San 
Diego, CA) to convert the mRNA in 100 ng of total RNA into a library of template 
molecules suitable for subsequent cluster generation and sequencing on the Illumina 
HiSeq 2500.  The input total RNA was quality-checked by running an aliquot on the 
Agilent Bioanalyzer to confirm integrity. The Qubit RNA fluorometry assay was used to 
measure concentration.  The input to library prep was 50 µl of 2 ng/µl DNase-treated total 
RNA. The total RNA underwent enrichment of the poly-A containing mRNA molecules 
using poly-T oligo-attached magnetic beads.  Following purification, the eluted poly(A) 
RNA was cleaved into small fragments of 120-210 bp using divalent cations under 
elevated temperature. The cleaved RNA fragments were copied into first strand cDNA 
using SuperScript II reverse transcriptase and random primers. This was followed by 
second strand cDNA synthesis using DNA Polymerase I and RNase H. The cDNA 
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fragments were then put through an end-repair process, the addition of a single ‘A’ base, 
and ligation to the Illumina multiplexing adapters. The products were then purified and 
enriched with PCR to create the final cDNA sequencing library. The cDNA library 
underwent quality control by running on the Agilent Bioanalyzer HS DNA assay to 
confirm the final library size and on the Agilent Mx3005P qPCR machine using the 
KAPA Illumina library quantification kit to determine concentration. A 2 nM stock was 
created and samples pooled by molarity for multiplexing.  From the pool, 12 pM was 
loaded into each well for the flow cell on the Illumina cBot for cluster generation. The 
flow cell was then loaded onto the Illumina HiSeq 2500 utilizing v3 chemistry and HTA 
1.8. The raw sequencing reads in BCL format were processed through CASAVA-1.8.2 
for FASTQ conversion and demultiplexing. The RTA chastity filter was used and only 
the PF (passfilter) reads were retained for further analysis. Raw expression data files are 
available from Gene Expression Omnibus (GEO accession: GSE47573; 
http://www.ncbi.nlm.nih.gov/geo/). 
Genome level alignments and annotation. Paired-end reads of 76 base length (each end) 
originating from each sample were aligned using Bowtie 0.12.7 (Langmead, Trapnell et 
al. 2009) to the S. pombe genome sequence (Ensembl S. pombe, Build EF1, version 13) 
(Kersey, Lawson et al. 2010) as well as to the corresponding exon-exon junctions 
database (only the first part of the paired-end reads was considered). Up to 3 base-pair 
mismatches were allowed. Reads that matched multiple loci were removed from further 
analysis, and the resultant alignment files were processed to generate ‘pile-ups’ against 
each chromosome.  
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Exon-exon junctions. Searches were performed against the genome sequence combined 
with a dataset of known exon-exon junctions as defined by Ensembl S. pombe release-13. 
To ensure that a 76 base read mapped to a splice junction, only the last 70 bases of the 
first exon and the first 70 bases of the second exon were considered (if the exon exceeded 
length 70). In this way, reads that overlapped a junction by less than 6 nucleotides were 
excluded. Reads that matched to more than one junction or elsewhere in the genome were 
also discarded. 
Defining Intronic, Antisense, and Intergenic Regions. The known annotated set of S. 
pombe loci (7,022; Ensembl version 13, as before) was used to define unambiguous 
antisense loci (i.e., those that exactly mirror known annotated transcripts without 
overlapping nearby genes), and unique accessions were assigned (“anti_xxx”; 3,097). 
Using this augmented annotation, intergenic regions were defined (i.e. regions between 
known annotated and antisense loci on each strand), and unique accessions were assigned 
(“inter_xxx”; 8,810). Unique accessions were also assigned to all known introns (5,361). 
Thus, in total 21,193 loci were interrogated across the 4 samples.  
Normalization, Fold Changes, and Differential Expression. Differential expression 
between samples was determined using the DESeq Bioconductor package (Anders and 
Huber 2010). A cutoff of ±2 fold-change and corrected p-value <0.05 were applied to 
derive a list of differentially expressed loci.  
RNA-seq Expression level. Normalized expression levels (E) for individual exons and 
introns were calculated using the formula [1] as described in (Mortazavi, Williams et al. 
2008, Bradford, Hey et al. 2010) (RPKM measure). Briefly, the number of reads (R) 
detected across a given region at a given sample (i) was multiplied by a constant (C =
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) and divided by the total number of reads at that sample (Ti) multiplied by the 
region’s length (L).  
        [1] 
 
A small constant was added (10-5) to all expression values to avoid taking logarithms of 
zero. Gene level expression values were summarized using exon data. 
Splicing Efficiency and Differential Splicing Significance. Splicing efficiency (SE) 
reflects the proportion of spliced mRNA signal relative to pre-mRNA signal. Splicing 
efficiency is computed by dividing junction reads (JR; aka trans-reads) by reads that 
straddle an exon-intron boundary (only the upstream 5’ exon relative to the intron was 
considered; EI; formula 2). 
                   [2] 
                 
A Cochran-Mantel-Haenszel (CMH) chi-squared test for repeated test of independence, 
which accounts for biological replicates (Agresti 1990), was applied to identify 
statistically significant introns (i.e., those that display differences in their splicing 
efficiency between samples; mantelhaen.test command in R). The False Discovery Rate 
(q-value) was computed using the bioconductor qvalue package (Storey 2002) and a 
cutoff of q < 0.05 applied.    
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Expression and Purification of Cwf10(1-135)His6 
The N-terminal 1-135 amino acid sequence of Cwf10 with 6 C-terminal histidine 
residues was cloned into pET15b (NcoI/BamHI; plasmid pOHI1020) (EMD Millipore) 
and transformed into E. coli Rosetta 2 (DE3) pLysS cells (EMD Millipore). Cells were 
grown in Terrific broth (Invitrogen, Grand Island, NY) to an OD595 of ~0.8 and cold 
shocked for 20 minutes on ice. Upon addition of 1 mM IPTG, the plasmid was 
overexpressed for 20h at 15°C. Cells were lysed in PBS (pH 7.0), 350 mM NaCl, 0.1% 
Triton X-100 and one SIGMAFAST protease tablet (Sigma-Aldrich, St. Louis, MO). 
Cwf10(1-135)His6 was purified using two 5 ml Histrap HP columns (GE Healthcare, 
Waukesha, WI) and a 2.5-500 mM imidazole linear gradient. Cwf10(1-135)His6 was 
further purified using anion-exchange (Uno Q1, Bio-Rad) chromatography in buffer A 
(50 mM Tris-HCl, pH 8.0) using a 0-1 M NaCl linear gradient, followed by gel filtration 
(Superdex 200, GE Healthcare) in 25 mM Tris-HCl (pH 7.3), 100 mM NaCl, and 1 mM 
EDTA. 
 
Circular Dichroism 
Purified Cwf10(1-135)His6 was analyzed using a Jasco J-810 spectropolarimeter 
(Jasco Analytical Instruments, Easton, MD).  Far-UV data were collected at a protein 
concentration of 0.18 mg/ml in a 1 mm quartz cuvette. Spectra were collected with an 
average time of 4 s for each point and a step size of 20 nm/min from 198 to 260 nm. Far-
UV spectra were collected in duplicate and background-corrected against a buffer blank. 
Spectra were analyzed using the program K2D2 (Perez-Iratxeta and Andrade-Navarro 
2008) to estimate secondary structure. Near-UV data were collected at a protein 
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concentration of 2.01 mg/ml in a 1 cm quartz cuvette.  Spectra were collected with an 
average time of 4 s for each point and a step size of 10 nm/min from 250 to 330 nm. For 
both Cwf10(1-135)His6 and Cwf10(1-135)His6 in 6 M guanidine-HCl five spectra were 
collected for near-UV data and background-corrected against a buffer blank.  Data were 
converted to mean residue ellipticity [θ]m (degrees cm2dmol−1) using [θ]m = θ/(10lcn), 
where θ is the measured ellipticity, l is the cell path length in cm, c is the molar 
concentration of protein in mol/liter, and n is the number of residues/chain.  
 
Analytical ultracentrifugation 
Purified Cwf10(1-135)His6 was run in an Optima XLI ultracentrifuge (Beckman 
Coulter, Brea, CA) equipped with a four-hole An-60 Ti rotor at 42,000 RPM at 4°C at 
0.45 mg/ml. Samples were loaded into double-sector cells (path length of 1.2 cm) with 
charcoal-filled Epon centerpieces and saphire windows. Sedfit (version 12.0) (Schuck 
2000) was used to analyze velocity scans using every five scans from a total of 167 scans. 
Approximate size distributions were determined for a confidence level of p = 0.95, a 
resolution of n = 300, and sedimentation coefficients between 0 and 5 S. 
 
NMR analysis 
Cwf10(1-135)His6 was purified as above except cells were grown and expressed 
in M9 media supplemented with 15N-labeled ammonium chloride (Cambridge Isotopes, 
Andover, MA) as the only nitrogen source, purified as described above, and 10% D2O 
was added to the final sample. During purification half of the sample was left in gel 
filtration buffer (25 mM Tris-HCl [pH 7.3], 100 mM NaCl, and 1 mM EDTA) and the 
            123
other half was buffer exchanged into gel filtration buffer plus 6 M guanidine-HCl. 
Standard sensitivity enhanced echo/anti-echo 15N-1H HSQC NMR data were collected at 
25°C for both samples and at 50°C for the gel filtration buffer sample (no Guanidine-
HCl) using a 600 MHz Bruker AVIII spectrometer (Bruker, Billerica, MA) with a 
CPQCI probe and z-axis gradient. The spectra were processed using Topspin 3.2 (Bruker, 
Billerica, MA). The indirect dimension was four times zero filled to a final matrix of 
2048 x 1024 data points and 720 and 900 squared sine bell apodization was applied in the 
F2 and F1 dimensions respectively. Spectra were further analyzed with Sparky (T. D. 
Goddard and D. G. Kneller, University of California, San Francisco). 
 
Mass spectrometry 
TAP elutions were trichloroacetic acid (TCA)-precipitated, resolubilized in 8 M 
urea, 100 mM Tris pH 8.5, reduced and alkylated, and then diluted back to 2 M urea and 
digested overnight with trypsin as described (MacCoss, McDonald et al. 2002). Resulting 
peptides (corresponding to about 5% of the TAP eluate) were analyzed by a 70 minute 
data-dependent LC-MS/MS analysis in the Vanderbilt Mass Spectrometry core. In brief, 
peptides were autosampled onto a 200 mm by 0.1 mm (Jupiter 3 micron, 300 Å) self-
packed analytical column coupled directly to an LTQ (ThermoFisher) using a 
nanoelectrospray source and resolved using an aqueous to organic gradient. A series of a 
full-scan mass spectrum followed by five data-dependent tandem mass spectra (MS/MS) 
was collected throughout the run and dynamic exclusion was enabled to minimize 
acquisition of redundant spectra. MS/MS spectra were searched via SEQUEST against a 
S. pombe database (UniprotKB taxon 284812– reference proteome set) that also 
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contained a reversed version for each of the entries (Yates, Eng et al. 1995). 
Identifications were filtered and collated at the protein level using Scaffold (Proteome 
Software).  
 
Negative-stain EM 
Uranyl formate-stained samples were prepared for EM as described (Ohi, Li et al. 
2004). In brief, 2.5 µl of sample was absorbed to a glow-discharged 400-mesh copper 
grid covered with carbon-coated collodion film. The grid was washed in two drops of 
water and then stained with two drops of uranyl formate (0.75%). Samples were imaged 
on a Morgagni electron microscope (FEI, Hillsboro, OR) operated at an acceleration 
voltage of 100 kV. Images were recorded at a magnification of 28,000 and collected 
using a 1K x 1K CCD camera (AMT, Wobum, MA). 
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Appendix E Table 1: Schizosaccharomyces pombe strains used in this 
study 
Strain Genotype Source 
OHI246 h- leu1-32 ura4-D18 ade6-M210 K. Goulda 
OHI408 h- cwf10 2-127Δ ade6-M21X leu1-32 ura4-
D18 
This work 
OHI479 h+ brr2-HA::kanR ade6-M210 leu1-32 ura4-
D18 
Adapted from K. 
Goulda 
OHI480 h+ prp3-linker3XV5 cwf10 2-127Δ ade6-
M21X leu1-32 ura4-D18 
This work 
OHI371 h+ prp3-linker3XV5 This work 
OHI482 h- brr2-HA::kanR cwf10 2-127Δ ade6-M21X 
leu1-32 ura4-D18 
This work 
OHI323 h- prp1-myc13X::kanR ade6-M210 leu1-32 
ura4-D18 
Carnahan, et al., 
2005 
OHI439 h- prp1-myc13X::kanR cwf10 2-127Δ ade6-
M21X leu1-32 ura4-D18 
This work 
OHI448 h- cwf10 2-127Δ::kanR ade6-M21X leu1-32 
ura4-D18 
This work 
OHI463 h+ cdc28-P8 Adapted from 
Nasmyth and 
Nurse, 1981 
OHI467 h+ cdc28-P8 cwf10 2-127Δ::kanR ade6-M21X 
ura4-D18 
This work 
OHI464 h+ prp10-1 Adapted from 
Urushiyama, et 
al., 1996 
OHI468 h+ prp10-1 cwf10 2-127Δ::kanR This work 
OHI466 h+ spp42-1::kanR leu1-32 Adapted from 
Schmidt, et al, 
1999 
OHI465 h+ spp41-1::kanR leu1-32 ura4-D18 Adapted from 
Schmidt, et al, 
1999 
OHI471 h+ spp41-1::kanR cwf10 2-127Δ ade6-M21X 
leu1-32 ura4-D18 
This work 
OHI322 h+ prp1-4 ura4-D18 Adapted from 
Urushiyama, et 
al., 1996 
OHI321 h+ prp4-73 leu1-32 ura4-294 Adapted from 
Rosenberg, et 
al., 1991 
OHI462 h- prp4-73 cwf10 2-127Δ::kanR leu1-32 ura4- This work 
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D18 or -294 
OHI478 h+ aar2::kanR ade6-M216 leu1-32 ura4-D18 Kim, et al., 2010 
OHI481 h- aar2::kanR cwf10 2-127Δ ade6-M21X leu1-
32 ura4-D18 
This work 
OHI487 h+ prp17::ura4+ ade6-M21X leu1-32 ura4-
D18 
Sapra, et al., 
2004 
OHI488 h+ prp17::ura4+ cwf10 2-127Δ::kanR ade6-
M21X leu1-32 ura4-D18 
This work 
OHI483 h+ cwf10 2-23Δ ade6-M21X leu1-32 ura4-
D18 
This work 
OHI383 h-/h+ cwf10+/cwf10::ura4+ ade6-M210/ade6-
M216 leu1-32/leu1-32 ura4-D18/ura4-D18 
This work 
OHI260 h- cdc5-TAP::kanR Ohi, et al., 2002 
aVanderbilt University School of Medicine, Nashville, TN. 
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Appendix E, Table 2: Primers used in this study 
Analysis Name Purpose Primer sequence(s) (5’-3’) 
RT-PCR tbp1_a F 
BL365 
amplify first 
tbp1 intron 
CGCTTTACCCACCACGGCCTCGCAAG 
RT-PCR tbp1_a R 
BL366 
amplify first 
tbp1 intron 
TTCTGCATTACGTGCATGTAGCGC 
RT-PCR mrps16_b F 
BL541 
amplify 
second 
mrps16 intron 
AAAGCACCTCAAGCCAAACCTATCGA 
RT-PCR mrps16_b R 
BL542 
amplify 
second 
mrps16 intron 
TCAAGAAACGGGTTTTTTAGGAAGCAACT 
Northern BL432 hybridize U1 ATAACTGAGTCTCCACAATTCTTGTG 
Northern BL429 hybridize U2 AGAACAGATACTACACTTGATCTAAG 
Northern BL433 hybridize U4 AAAAGTTCCTCACTGATAAGCGTAAT 
Northern BL434 hybridize U5 ACAGTCAAATTAGCACACCTTACAAA 
Northern BL435 hybridize U6 TCTTCTCTGTATCGTTTCAATTTGAC 
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